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ABSTRACT
DUAL-MODALITY SMARTPHONE-BASED FIBER-OPTIC
MICROENDOSCOPE SYSTEM FOR EARLY
DETECTION OF CERVICAL
NEOPLASIA

Xiangqian Hong, B.S., M.E.
Marquette University, 2019

Cervical cancer remains the leading cause of death for women in low middleincome countries (LMICs), where the incidence and mortality of cervical cancer are
disproportionately high. Due to the poor medical conditions and lack of resources, the
benefits of early screening methods such Pap smear and HPV test have yet to be realized
in these areas. The more viable screening option - visual inspection with acetic acid
(VIA) is relatively easier to implement and lower in cost. However, the effectiveness of
VIA on the early detection of cervical cancer is still in question because of its low
specificity, which may lead to many unnecessary follow-up diagnoses and treatments.
Optical endoscopy is a powerful tool for detecting pre-cancerous changes in the
epithelial tissue of the cervix. In this dissertation, we report the design and development
of a dual-modality fiber-optic microendoscope system (SmartME) that integrates highresolution fluorescence imaging (FLI) and quantitative diffuse reflectance spectroscopy
(DRS) onto a smartphone platform. A smartphone App has also been developed to
control the SmartME, pre-process the data, and wirelessly communicate with a remote
server where the image and data are processed to extract diagnostically meaningful tissue
parameters. The SmartME device has been thoroughly tested and calibrated. The FLI has
a spatial resolution of ~3.5 µm, which allows imaging of subcellular organelles and
determining the nuclear-cytoplasmic ratio of epithelial tissues. The DRS has a spectral
resolution of 2 nm and is capable of measuring optical properties of epithelial tissues with
a mean error of ~5%, which is comparable to what can be achieved with a commercial
spectrometer. The feasibility of the device in measuring biological samples has been
verified ex vivo using monolayer cervical cancer cells, tumor tissue from xenograft solid
tumor models and other normal tissues. In vivo study on healthy human oral mucosa
tissues has demonstrated that the SmartME can noninvasively quantify the tissue
parameters and distinguish between different tissue types. The SmartME may provide a
compact, cost-effective, and globally connected solution for early detection of neoplastic
changes in epithelial tissues.
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CHAPTER 1: INTRODUCTION AND BACKGROUND

1.1 CERVICAL CANCER
1.1.1 HPV infection leads to cervical cancer
Human papillomavirus (HPV) is a widespread viral infection of the reproductive
tract.[1] Although about 90% HPV infections disappear spontaneously without any
medical intervention in 6 months to 2 years [2], persistent infections with certain cancercausing HPV may become chronic and pre-cancerous lesions, progress either to highgrade cervical intraepithelial neoplasia (CIN) or to invasive cancer.[3] More than 150
different types of HPV have been identified, of which 14 HPV types, including HPV 16,
18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68, are considered cancer-causing or
“high-risk”.[4] Particularly, HPV 16 and 18 are most commonly associated with the
development of cervical cancer and are known to cause more than 70% of all cervical
cancers.[1] A 60-year study evaluating HPV infections in more than 10,000 confirmed
invasive cancer cases in 38 countries around the world has revealed that cancercausing types of HPV are detected in nearly all cervical cancers.[5]
1.1.2 High incidence and mortality rates in LMICs
Globally, cervical cancer remains the fourth most common cancer in women with
an estimated 570,000 new cases in 2018 and 311,000 deaths every year.[6] Besides, the
number of deaths keeps increasing and it is estimated to reach 460,000 per year by 2040.
In 2018, approximately 84% of new cases and 90% of deaths due to cervical cancer occur
in LMICs.[6] Figure 1-1 shows the latest incidence and mortality rates of cervical cancer
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worldwide. The disproportionately high incidence and mortality rates in LMICs are
mainly due to limited access to early preventative methods. In most cases, cervical cancer
is not detected until it has processed to invasive cervical cancer in these countries,
resulting in a higher rate of death from cervical cancer.

Figure 1-1: Estimated cervical cancer incidence and mortality rates worldwide in 2018

1.2 CERVICAL CANCER SCREENING
In general, the precancerous change of cervical tissue can be classified into three
stages, namely CIN1/CIN2/CIN3, based on the thickness of the affected epithelium
tissue. CIN1 is the mild intraepithelial neoplasia when one-third of the epithelium is
affected. While the higher degree lesions, CIN2 and CIN3 have dysplasia about two

3
thirds and all of the epithelium layer, respectively.[7] The high-grade cervical
intraepithelial neoplasia (CIN2+) will eventually progress into invasive cancer if left
untreated (Figure 1-2). Early detection and treatment is the key to saving a patient's life.
Early screening allows pre-cancerous lesions to be detected at an early stage when
treatment has a high cure rate. Studies suggest that ~90% of the patients who were
diagnosed at an early stage (stage I) lived more than five years, while the 5-year survival
rates for stage II and III are less than 50% and 10%, respectively.[8]

Figure 1-2: Schematics of cervical intraepithelial neoplasia development
(Photo credit: Novikova, T. Adapted from reference 7)

1.2.1 Screening in developed countries
In developed countries, a comprehensive approach has been developed for
cervical cancer prevention, diagnosis and treatment. It includes HPV vaccination of girls
starting as early as age 9, regular screening and diagnosis, and treatment of pre-cancer
lesions for women from age 30. Particularly, the regular screening allows pre-cancerous
lesions to be detected at an early stage when treatment has a high cure rate. In the US,
cervical cancer deaths have been reduced by 70% since 1941 when the Papanicolaou
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(Pap) smear screening was first introduced.[9] Pap smear screening is still the primary
approach in early detection of cervical cancer at present. The common procedures of a
Pap smear test involve the collection of cells from the cervix for microscopic
examination and identification of abnormal cells based on cytological characteristics,
such as altered nuclear shape and increased nuclear size, which have been reported to be
associated with cancer cells.[10] The Bethesda system (TBS) is a widely used system for
reporting Pap smear results. A low-grade squamous intraepithelial lesion (LSIL) usually
indicates mild intraepithelial neoplasia (CIN1). Expanded nucleus with a size at least
three times bigger than the normal nucleus can be observed, leading to an increased
nuclear-cytoplasmic ratio (N/C). A high-grade squamous intraepithelial lesion (HSIL)
indicates moderate intraepithelial neoplasia (CIN2) and severe intraepithelial neoplasia
(CIN3). Cells in HSIL have expanded nuclei with reduced cytoplasm, leading to an even
larger N/C than LSIL, as illustrated in Figure 1-3[11]. Studies have shown that using
nuclear morphometry such as nuclear size/diameter[12] and N/C[13] can effectively
differentiate LSIL from HSIL and malignant cervical smears. The collected cells during a
Pap smear test can also be used for the HPV test, which has been typically used as an
adjunct to the Pap smear because of the high prevalence of HPV infection in the absence
of cervical disease.[14]
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Figure 1-3: Morphology of cervical epithelial cells
(Photo credit: Yang, L., et al. Reference 11)

1.2.2 Screening in LMICs
Due to the lack of resources in LMICs, the benefits of the regular cervical cancer
screening have yet to be realized in LMICs.[15-17]. Employing Pap smear and HPV test
requires multiple visits, a centralized laboratory, and skilled staff for processing and
evaluation of cytology, virology, and pathology specimens.[18,19] The Alliance for
Cervical Cancer Prevention has suggested a see-and-treat paradigm for cervical cancer
prevention in LMICs.[20] The most viable option is to screen using a more cost-effective
method called visual inspection with acetic acid (VIA) or VIA with magnification
(VIAM) and to treat the pre-cancerous lesions using loop electrosurgical excision
procedure (LEEP) or cryotherapy.[21-23] Performing a VIA test starts with a vaginal
speculum exam during which diluted acetic acid (5%) will be applied to the cervix. Due
to the acetowhitening phenomenon, as shown in Figure 1-4, the tissue in the abnormal
area will temporarily turn white when exposed to acetic acid. Suspicious lesions will be
identified by viewing the cervix to identify color changes on the cervix. [24,25] However,
studies have shown that the acetowhitening phenomenon is not exclusive to precancerous
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lesions, normal epithelial tissue with infection or inflammation may appear similar to the
positive ones, which leads to a lower accuracy for pre-screening. Although coagulation of
the nucleoprotein and polymerization of cytokeratin have been hypothesized as the
physical origin of the acetowhitening phenomenon[26,27], the mechanism of
acetowhitening effect is still not fully understood.[28] Many efforts have been made to
improve the performance of acetowhitening-based inspection, including modeling the
temporal pattern of acetowhitening (rising and decay)[29-31] or quantitatively measuring
the intensity of backscattered light during acetowhitening process[32-34] in benign and
suspicious lesions. However, large variability in findings or even contradictory results in
the acetowhite temporal patterns were observed from measurements in the cell
suspension[28] and tissue in vivo[32,33]. The acetowhite rising and decay pattern is highly
dependent on the concentration of acetic acid applied and is very sensitive to the physical
conditions of the tissue which are related to patient age and race, the stage of
menstruation, or the way colposcopy is performed.[35]

Figure 1-4: Acetowhitening phenomenon during VIA test
(Photo credit: Gaffikin et al. Adapted from reference 24)
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1.2.3 Challenges for cervical cancer screening in LMICs
Sensitivity and specificity are two statistical measures that are widely used to
quantify the diagnostic performance in medical diagnosis. Sensitivity, also known as the
true positive rate, measures the proportion of patients with the disease who will be
identified to have a positive result. Specificity, also known as the true negative rate, is
defined as the proportion of patients without the disease who will be identifies to have a
negative result. Table 1-1 illustrates the effectiveness of VIA/VIAM in terms of
sensitivity and specificity when compared to the Pap smear test. Although the sensitivity
of the VIA/VIAM approach is as good as, if not better than, the Pap smear, the specificity
is significantly lower.[36-39] In a see-and-treat paradigm, this would cause a large amount
of overtreatment and unnecessary health care (e.g., biopsy and follow-ups), which would
reduce the effectiveness of this approach. Consequently, there is a critical global need for
affordable, effective point-of-care strategies to improve the screening and early
diagnostic rates of cervical cancer in LMICs.

Table 1-1: Effectiveness of current cervical cancer screening methods

1.3 OPTICAL ENDOSCOPY FOR CERVICAL NEOPLASIA DETECTION
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Biophotonics is an emerging interdisciplinary field that studies biomolecules,
cells and tissues using optical techniques. The advent of optical endoscopy techniques
has made it possible to noninvasively acquire biological and morphological information
deep within the cervical tissue. White light endoscopy, such as reflectance colposcopy, is
a standard tool that has been extensively used in cervical cancer screening, diagnosis, and
treatment. In the past decades, various high-resolution imaging modalities, including
optical coherent tomography (OCT),[40-44] Raman spectroscopy,[45-50] fluorescence
imaging,[51-53], fluorescence spectroscopy[54-56], diffuse reflectance spectroscopy,[57-61] and
photoacoustic imaging[62,63] narrow-band imaging,[64-67] have been successfully
incorporated into endoscopic probes for early detection and delineation of epithelial
neoplasia.
1.3.1 Optical coherence tomography
Studies on OCT have been growing rapidly in recent years. It is one of the most
promising technologies for non-invasive imaging of biological tissue, especially in the
clinical diagnosis of ophthalmology, dentistry and dermatology. OCT uses near-infrared
light and low-coherence interferometry to take cross-sectional images of the internal
structure of the biological tissue. By using the principle of interference, signals of tissue
at different depths can be obtained. OCT provides a typical resolution of 1-15 μm and up
to 4 mm penetration depth by using near-infrared light.
Researchers have conducted pilot studies on applying OCT in the detection of
cervical neoplasia. Gallwas et al. reported a sensitivity of 95% and a specificity of 46%
for the detection of neoplasia and cancerous lesions using OCT in 60 patients.[68] Another
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study on discriminating different CIN grades in 120 patients achieved an averaged
sensitivity of 97% and specificity of 40%, respectively, with the threshold at CIN 1. The
sensitivity decreased to 85% with the threshold at CIN 2, while the specificity increased
to 62%.[40] These studies demonstrate the high sensitivity of OCT in distinguishing
neoplasia grades and cancerous lesions. However, it was relatively more difficult to
differentiate the CIN1 and the healthy tissue (false positive) due to other benign
modifications, which resulted in a much lower specificity of OCT. The same group
reported improved specificity of 69% in a more recent study by combining OCT and
microscopy.
1.3.2 Raman spectroscopy
Raman spectroscopy is another promising tool that can be used in the early
diagnosis of cancer due to its capability of obtaining highly detailed spectroscopic
information of the tissue. During the development of cancer, the structure of proteins,
nucleic acids, lipids, and carbohydrates changes. These changes can be effectively
detected by Raman spectroscopy to reveal the underlying molecular structure and
precancerous modifications. Raman spectroscopy can provide rich structural features and
molecular fingerprint at the molecular level.
The feasibility of using Raman spectroscopy as a label-free diagnostic method for
the early detection of cervical cancer has been studied by different groups. Duraipandian
et al. achieved an average accuracy of 82.6% by using simultaneous fingerprint and highwavenumber confocal Raman spectroscopy in an in vivo study.[50] Another study
indicates that Raman spectroscopy can discriminate high-grade dysplasia lesions from
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healthy tissue with a sensitivity of 89% and specificity of 81%, both are higher when
comparing to regular colposcopy, which has a sensitivity and specificity of 87% and
72%, respectively. [69]
1.3.3 Fluorescence imaging
Endoscopic FLI with a fluorescence dye allows imaging of subcellular organelles,
such as cell nuclei of the mucosa of the cervix. To improve the efficacy of cervical cancer
screening in LMICs, fiber-optic endoscopes have been developed for high-resolution
fluorescence imaging of cell nuclei.[30,51,70,71] The Richards-Kortum group reported a
high-resolution fluorescence microendoscope (HRME)[72,73], shown in Figure 1-5, based
on a fiber bundle for molecular imaging of cell culture and living tissue. Two pilot
studies conducted by Pierce et al. and Quinn et al. demonstrated the use of nuclearcytoplasmic ratio (N/C) obtained with the HRME achieved a sensitivity of 100% and
specificity of 65%,[52] and a sensitivity of 86% and specificity of 87%,[53] respectively, in
differentiating CIN2+ lesions from non-neoplastic cervical tissues.

Figure 1-5: HRME system developed by Richards-Kortum group
(Photo credit: Grant, B. D, Springer. Reference 64)
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However, the reported HRME system uses expensive components such as the
scientific camera[72] or DSLR camera[74], and the system has to connect to a local
computer, which limits its portability and makes the system less easy-to-use. Therefore,
additional studies are required to reduce the size and cost of the endoscopic fluorescence
imaging system while maintaining its effectiveness in the early detection of cervical
cancer.
1.3.4 Diffuse reflectance spectroscopy
Diffuse reflectance spectroscopy is very sensitive to the optical properties of
epithelial tissue[75-78] and has demonstrated its potential for early detection of cancers in
cervix,[79-84] oral cavity,[85-89] colon,[57,61,90,91] and Barrett's esophagus.[58,59,92] The
absorption (𝜇𝑎 ) and reduced scattering coefficients (𝜇𝑠′ ) of epithelial tissues reflect their
underlying physiological and morphological properties.[93] For instance, dominant
absorbers in the visible wavelength range in cervical tissues include oxy-hemoglobin and
deoxy-hemoglobin, arising from blood vessels in the stroma. Light scattering is primarily
caused by cell nuclei and organelles in the epithelium and stroma, as well as collagen
fibers and cross-links in the stroma. Neoplastic epithelial tissue exhibits significant
changes in their physiological and morphological characteristics that can be quantified
optically given that the stromal layer absorption is expected to increase with
angiogenesis,[78,84,94-96] resulting in decreased stromal scattering with the neoplastic
progression that coincides with the degradation of extracellular collagen
networks.[78,85,93,97-99] In contrast, epithelial scattering increases due to increased nuclear
size and DNA content, as well as hyperchromasia.[78,84,93,94,100] In the visible wavelength
range, DRS has a penetration depth that can be tuned to be comparable to the thickness of
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the epithelial layer or deeper to probe both the epithelial and stromal layers.[77,94,101]
These advantages enable DRS to be used as a cost-effective (<$5,000), fast and sensitive
tool for early detection of cervical cancer. Thekkek et al. have summarized several
studies on cervical tissue optical spectroscopy[51], in which DRS was shown to achieve
sensitivities and specificities in the ranges of 83 – 92% and 80 – 90%, respectively.[18]
1.3.5 Combined techniques
While imaging and spectroscopy are being actively studied, few imaging or
spectroscopy modalities alone can achieve the high sensitivity and specificity required for
early cancer detection, and often two or more are required to provide the physician or
computer algorithm with complementary information about the lesion in question. A
technique that is superior on one side may have limitations on the other side so that its
application will be limited. For example, OCT allows high-resolution imaging at larger
depths but cannot provide functional information of the tissue. Raman spectroscopy
provides highly detailed spectroscopic information but has very week signal and small
field of view that limited within a small range of wavenumbers. Recent years have seen
increasing research on the integration of multiple imaging modalities into a single device
to obtain complementary tissue information.[102-104] Freeberg et al. developed an
instrument that combined fluorescence and reflectance spectroscopy for the detection of
cervical neoplasia. An 850-patient clinical study using the instrument has shown
significant differences in mean intensity between normal and high-grade tissue.[105]
Similar device developed by Twiggs et al. that combines fluorescence and reflectance
spectroscopy achieved a sensitivity of 91.3% in differentiating high-grade lesions
(CIN2+).[106] However, the instruments used in both groups are not portable or globally
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connected. The devices have to be connected to and controlled by a local computer for
data acquisition and analysis, which limits their application in LMIC.
However, because most of these modern optical imaging methods are still in the
early stage of development, it is hard to judge the diagnostic efficacy of each imaging
modality.[107] Table 1-2 summarizes the performance and research status of several
common optical imaging techniques. The major drawbacks of current high-resolution
endoscopes are the use of expensive (over $10,000) and power-consuming light sources
and detectors. Moreover, they often need experienced engineers to operate the
sophisticated instruments and physicians to interpret the images, making them
unaffordable to LMICs. Besides, some systems require a scanning mirror inside the
endoscopes, which is bulky and incompatible with magnetic resonance imaging and
computerized tomography scanners.

Table 1-2: Summary of advanced optical techniques in cervical cancer detection
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1.4 SMARTPHONE IN HEALTHCARE
The cost of wireless technology has decreased over the years[108], thereby making
smartphones, a subset of mobile phones, a very affordable device, even for people living
in many rural areas and developing countries. The International Telecommunication
Union reported that the mobile-broadband subscriptions reached 4.3 billion globally in
2017; Between 2012 and 2017, the most rural areas saw the largest growth rate of mobile
broadband subscriptions. Mobile broadband becomes more affordable than fixed
broadband in most developing countries.[109] In addition to a high-resolution camera,
smartphones also offer enormous computational power and wireless Internet access. The
smartphone-based diagnosis could potentially reduce healthcare costs, provide wireless
access to advanced laboratories, and experienced physicians in developed countries, thus
revolutionizing healthcare delivery in LMICs.
Smartphones are playing an emerging role in optical imaging for medical and
biological applications — for example, Breslauer et al.[110] reported a mobile phone
microscope with a field-of-view (FOV) of 180 µm in diameter and a 1.2 µm resolution
for the diagnosis of hematologic and infectious diseases. Switz et al.[111] added a reversed
camera lens to a mobile phone to enable high-quality imaging over a FOV of ~10mm2
and successfully identified red and white blood cells in blood smears and soil-transmitted
helminth eggs in stool samples. Tseng et al.[112] demonstrated a lens-free holographic
microscope on a mobile phone that has been used to image variously sized
microparticles. Zhu et al.[113] reported wide-field FLI on a mobile phone over a FOV of
∼81 mm2 with a resolution of ∼20 μm. Smartphone spectrometers with nanometer to
sub-nanometer accuracy have also been reported.[114-120] Gallegos et al.[115] demonstrated
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the use of a smartphone spectrometer to measure shifts in the resonant wavelength of a
label-free photonic crystal biosensor with 0.009 nm accuracy. Edwards et al.[120] reported
a miniature, visible to near-infrared G-Fresnel spectrometer that connected with a
smartphone through a Micro USB port for measurement of hemoglobin. Wang et al.[118]
have proposed multiple methods for implementing smartphone-based spectroscopy.
Smith et al.[117] developed two attachments that transform a phone camera into either a
microscope or a spectrometer.
Most smartphone imaging/spectroscopy devices utilize an external module
attached to the rear camera of a smartphone, but only a few attachments have been
designed for a fiber-optic endoscope. Bromwich et al.[121] proposed an adaptor for
coupling a traditional endoscope to a videophone for transmitting images collected by the
endoscope to a remote observer. Wu et al.[122] recently transformed a smartphone into an
endoscope for acquiring otorhinoscopic images from six patients for remote diagnosis.
Jongsma et al.[123] developed an otoendoscope system based on a mobile phone, which
has been commercialized by Endoscope-i Ltd. MobileOCT has recently marketed a
multimodal smartphone imaging system that can simultaneously undertake bright-field,
polarization difference, and spectral imaging with applications for cervical cancer
detection in developing countries.[124] The device uses a rigid imaging tube and requires
sophisticated imaging optics; thus, its application in LMICs is limited.
1.5 SOLUTION: SMARTPHONE-BASED DUAL-MODALITY FIBER-OPTIC
MICROENDOSCOPE
To fulfill the urgent need of practical and efficient approaches for cervical cancer
screening in LMICs and reduce the cost of optical endoscopes, we have designed and
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developed a portable, cost-effective, and easy-to-use optical microendoscope system,
named SmartME and tested its capability of characterizing biological properties in vivo.
The device consolidates the optical endoscope technologies into a smartphone platform
that is capable of performing both fluorescence imaging and diffuse reflectance
spectroscopy. This solution takes the advantages of both methods and provides highresolution imaging and quantitative information about the tissue physiology. We
hypotheses that 1) there are significant differences in the biomarkers (nuclear size and
density, hemoglobin concentration, absorption, and scattering) among high- and lowgrade lesions and their normal/benign counterparts, and 2) these contrasts can be detected
by the proposed dual modality device.
1.6 OUTLINE OF THEIS
The development procedures of the SmartME device involve instrumentation of
smartphone-based FLI and DRS separately and combination of two imaging modules
together. In Chapter 2, we described the design and development of a smartphone-based
fiber-optic microendoscope for high-resolution fluorescence imaging and present the
procedure and results of performance characterization. The design was first simulated and
optimized in Zemax OpticStudio to fulfill the high-performance requirements. The
imaging system was characterized using a 1951 USAF target to determine its spatial
resolution. With the help of fluorescence contrast agent proflavine, high-resolution
fluorescence images were successfully taken from biological samples to evaluate its
performance. Image processing approaches to remove the fiber bundle artifacts and
extract N/C from the fluorescence images were developed.
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In Chapter 3, we present the design and development of a smartphone-based
spectrometer for diffuse reflectance measurement. The design was also simulated and
optimized in Zemax to evaluate its feasibility. The developed DRS system was
characterized and calibrated using two calibration lamps. An optical resolution of 2 nm
was estimated, which is comparable to a commercially available benchtop spectrometer.
Tissue-mimicking phantom experiment was performed to evaluate the accuracy of the
system in measuring diffuse reflectance and extracting optical properties based on a fast
Monte Carlo model. An averaged error of less than 5% was achieved, which is also as
good as a commercial spectrometer that has been extensively verified in clinical studies.
In Chapter 4, we demonstrated the instrumentation of the dual-modality fiberoptic microendoscope SmartME by combining the FLI and DRS together. The SmartME
has a spatial resolution of ~3.5 µm for FLI and high accuracy in measuring diffuse
reflectance in tissue. A smartphone App has also been developed to control the phone
camera, collect the images/spectra, and communicate with the remote server. When used
with the App, the device can take FLI and DRS measurements on epithelial tissues,
wirelessly transfer the data to the server for real-time data processing, and return the
results to the SmartME within a minute. Our preliminary studies have demonstrated that
the dual-modality SmartME can accurately characterize the biological properties and
provide complementary information about epithelial tissues. The SmartME has great
potential to provide a compact, cost-effective, and ‘smart’ solution for early detection of
neoplastic changes in epithelial tissues, especially in low resource settings.
Chapter 5 summarizes the achievements and current limitations of the dissertation
work and discusses the future work to further improve the SmartME device and fully
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investigate the potential of the SmartME for early detection of neoplasia in epithelial
tissues in clinical studies.
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CHAP CHAPTER 2: SMARTPHONE-BASED FLUORESCENCE IMAGING

Portions of this chapter are derived from the following publication:
Hong, X., Nagarajan, V. K., Mugler, D. H., & Yu, B. (2016). Smartphone
microendoscopy for high resolution fluorescence imaging. Journal of Innovative Optical
Health Sciences, 9(05), 1650046.[108]
In this chapter, we described the design and development of a smartphone-based
fiber-optic microendoscope for high-resolution fluorescence imaging and present the
procedure and results of performance characterization. The design was first simulated and
optimized in Zemax to fulfill the high-performance requirements. The developed system
was characterized using a 1951 USAF target to determine its spatial resolution. With the
help of fluorescence contrast agent proflavine, high-resolution fluorescence images were
successfully taken from biological samples to evaluate the performance of the system.
The experiments have demonstrated the potential of developing a compact, easy-to-use
and cost-effective smartphone-based microendoscope to improve the screening and early
diagnostic rates of many medical conditions in LMIC.
2.1 INTRODUCTION
2.1.1 Fluorescence process
Fluorescence is a form of photoluminescence that occurs in certain molecules
called fluorophores. When a fluorophore is irradiated with light at a specific wavelength,
it absorbs light energy and enters to an excited state, then immediately retreats and emits
light with wavelengths longer than the incident light. This three-stage process is
illustrated by the Jablonski diagram[125] in Figure 2-1.
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Figure 2-1: Jablonski diagram illustrating the three-stage process of fluorescence

Absorption and excitation: when a fluorescent molecule absorbs the energy of
the incident light, the electrons in it are stimulated from the ground state 𝑆0 to the excited
state 𝑆1′, so that 𝑆0 + ℎ𝜐𝐸𝑋 = 𝑆1′ , where h is the Planck constant, 𝜐𝐸𝑋 is the frequency of
the incident photon.
Non-radiative transition: Electrons in the excited state can release their energy
and transit to the ground state in different ways. In a non-radiative transition process,
electrons can transit from the excited state 𝑆1′ via a very fast (less than a picosecond)
without radiation to a slightly lower excited state 𝑆1. The energy difference between the
two excited states is called the Stokes Shift.
Emission: The excited states are unstable so that electrons at the excited state 𝑆1
will transit back the ground state 𝑆0 . When the electrons are restored to the ground state,
the energy is released in the form of light. The light emitted here is fluorescence, and its
frequency is 𝜐𝐸𝑀 , so that 𝑆1 = 𝑆0 + ℎ𝜐𝐸𝑀 . The energy of the emitted photon is lower
than the excitation photon due to energy loss (heat) during the non-radiative transition,
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and therefore fluorescence usually has a longer wavelength. The ratio of the total number
of photons emitted to the total number of photons absorbed is called quantum yield.
Excitation spectrum and emission spectrum are two important indicators for
characterizing fluorescent materials. In general, one fluorophore material can be excited
by light at different wavelengths. Their emitting fluorescence can also cover a certain
range of wavelengths. The excitation spectrum refers to the relationship between the
intensity of the emission and the excitation wavelength. Based on the excitation
spectrum, the wavelength range of the excitation light required to illuminate the
fluorophores can be determined, and the optimal excitation wavelength at which the
intensity of a certain emission is maximum can also be determined. The emission
spectrum refers to the intensity and energy distribution of light of different wavelengths
emitted by excitation at a specific wavelength. A typical illustration of excitation and
emission spectra is presented in Figure 2-2.

Figure 2-2: Excitation and emission spectra (generic)
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2.1.2 Absorption and fluorescence of Proflavine
Proflavine, an acriflavine derivative, was first introduced into clinical use in 1917
for antiseptic applications.[126] It was typically used as an antiseptic drug that can be
topically applied on the skin,[127] based on its capability to induce a genetic mutation by
intercalating the DNA. This preferential cell nuclei staining property has later been
shown to provide strong fluorescent contrast, allowing for its applications in endoscopic
fluorescence imaging.[128] The measured absorption peaks of proflavine in the water at
PH = 7 are 260 nm around 445 nm[129-132] and exhibits a fluorescence emission centered
at 515 nm, with a quantum yield of 0.34.[133,134]

Figure 2-3: The fluorescence excitation and emission spectra of Proflavine in water
(Photo credit: Scott Prahl, OMLC. Reference 122)

2.2 OPTICAL DESIGN
2.2.1 System layout
The smartphone-based fiber-optic microendoscope consists of a smartphone with
a rear camera, imaging optics which was engineered as an attachment, and a fiber optic
imaging bundle. A schematic diagram of the smartphone microendoscope is shown in
Figure 2-4. The imaging optics include a band-pass filter for fluorescence excitation
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(BP1), a dichroic beamsplitter (DBS), a finite microscope objective (OBJ), a band-pass
fluorescence emission filter (BP2), an eyepiece (EP). The filtered excitation light from a
blue light emitting diode (LED) propagates through a condenser lens (CL) and be
redirected by the beamsplitter towards the objective to achieve a Kohler illumination
(uniform illumination) on the proximal end of the fiber bundle plugged into the FC/PC
connector. The distal end of the imaging bundle is in contact with the target being tested,
such as biological tissue. The fluorescence emissions from the target are collected by the
same fiber bundle, propagate through the objective, beamsplitter and emission filter that
blocks the excitation lights, and then enter the rear camera of the smartphone after being
collimated by the eyepiece.

Figure 2-4: Schematic diagram of the smartphone microendoscope for FLI
EP – eyepiece; BP1 and BP2 – optical bandpass filters; DBS - dichroic beamsplitter; OBJ –
microscope objective; L1 – condenser lens; LED - light-emitting diode; GND – ground; SW –
ON/OFF switch
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The use of off-the-shelf optic components in optical system design can provide
tremendous advantages in terms of reduced cost and development effort. Hence finding
the most appropriate stock optics is critical to the system development. Zemax is a widely
used optical design program that offers features and functions for comprehensive
analysis, simulation and design. The design follows the system layout shown
schematically in Figure 2-4. The blue beam represents the propagation of the blue LED
light source. The green beam represents the in-focus fluorescence captured by the phone
camera. The fluorescent microendoscope is designed in two major modules:
•

Imaging module: Microscope objective to the eyepiece lens and cellphone
camera.

•

Illumination module: Light focusing system to the microscope objective to
deliver excitation light to the fiber bundle.

2.2.2 Simulation of imaging module
Simulation of the imaging module was to determine the specification of optical
lens to be used and the overall size of the design. It starts with sequentially defining each
surface/element in the lens data editor (LDE), as shown in Table 2-1. A triplet lens and a
doublet lens were used to represent the achromatic objective lens and eyepiece lens,
respectively. This method is the easiest way to give enough degrees of freedom for
optimization to further overcome aberrations. A 1 mm thick glass plate after the last
objective element was added and tilted by 45 degrees about the x-axis to model the
decenter introduced by the dichroic beamsplitter in the system, followed by a single
surface to represent the emission filter. Note that coating profiles of the dichroic mirror
and emission band-pass filter were not pre-defined to simplify the design process because
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the introduction of these elements should not affect the imaging quality. A general
cellphone camera module was imported and placed at the end of the system to become
the last element. The total track length was required to be less than 200 mm. Vary the
radii and thicknesses of each surface in the LDE to optimize the imaging quality. Figure
2-5 depicts the design simulation.

Figure 2-5: Simulation of fluorescence imaging system
Elements from left to right: objective lens, dichroic beamsplitter, emission filter, eyepiece lens,
and cellphone camera. The coating profiles of the mirror and filter were not defined in the design.
Table 2-1: Values defined in the LDE for FLI module (optimized)
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In an optical system design, aberrations take place when light from one point of
an object diverge from a single point after traveling through the system. An optical
designer must correct the aberrations because they cause the image formed by the system
to be blurred or distorted. The most common types of optical aberrations include
spherical aberration, astigmatism, chromatic aberration, defocus, coma, and Petzval field
curvature. The image simulation feature of Zemax simulates the image formed by the
optical system when a 2D picture is imaged through it. It is ideal for characterizing the
real performance of an optical system. A built-in full-color bitmap, as shown in Figure 26(left), was used to simulate the imaging quality of the FLI system. Due to optical
aberrations, the blurry image in the middle was generated by the FLI system before
optimization. Details of the picture, especially the tiny objects such as the leaves and the
human figures, became indistinguishable. Furthermore, although the achromatic
objectives are corrected for axial chromatic aberration and spherical aberration in color, it
will still result in uneven distribution of light from the center to the edge of the field-ofview. Correction for flatness of field is required for a better performance. In addition to
the imaging quality, a proper magnification was required so that the images occupy the
most area of the camera sensor. Based on the camera specification of Moto G (1st Gen),
the optimized simulation suggested that using a 20X plan achromatic objective
(AmScope PA20X-B) with a wide-field 16X eyepiece (AmScope EP16X23-S) would
provide required imaging performance and in the meantime most of the sensor area
would be used. The objective has a numeric aperture of 0.40 (larger than the NA of the
imaging bundle 0.39) and standardized tube length of 160 mm.
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Figure 2-6: Simulation of imaging quality

2.2.3 Simulation of illumination module
The selection of the light source, excitation filter, dichroic beamsplitter and
emission filter is based on the use of the fluorescence dye. Therefore, the purpose of the
illumination simulation was to simulate how much light power could be obtained out of
the fiber image bundle by using the selected optical components when combining the
illumination and imaging modules. In this study, a blue LED (455 nm, M455L3,
Thorlabs), excitation filter (FF01-452/45, Semrock), dichroic beamsplitter (475 nm
cutoff, 475DCXRU, Chroma Technology), and emission filter (FF01-550/88, Semrock)
were used based on the use of proflavine (Sigma-Aldrich P2508), a topically applied
DNA dye, as the fluorescence contrast agent. The peak excitation and emission
wavelength of proflavine are 445 nm and 515 nm, respectively. The fiber bundle (FIGH30-650S, Fujikura) has an imaging area of 600 μm and consists of ~30,000 individual
fibers of ~3 μm in diameter with a center-to-center distance about 3.3 μm. The single
core has a numerical aperture (NA) of approximately 0.39.
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Table 2-2: Non-sequential component editor including illumination module

Both sequential ray tracing and non-sequential ray tracing are available in Zemax.
In the sequential mode, all of the rays traced must propagate through the same predefined
set of surfaces in the same order. By contrast, rays in non-sequential mode can propagate
through the optical components in any order and can hit the same object multiple times.
The simulation of the illumination was first done in sequential mode. The illumination
ray profile of LED is provided by Thorlabs so that it can directly be loaded to the design.
Surfaces of the condenser lens were created with preliminary radii of the lens surfaces for
further optimization. The illumination module was then combined with the imaging lens
system and converted into the non-sequential mode. In the Non-Sequential Component
editor shown in Table 2-2, a detector surface (Object 12) was created on the plane of the
proximal end of the fiber bundle so that the light power detected on this surface would be
treated as the power coupled into the fiber bundle, given that the numerical apertures of
the objective lens and the fiber bundle were matched.
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The surface of the dichroic beamsplitter and fluorescence filters were coated in
this modeling to simulate the real situation. A coating file of the front surface of the
dichroic was added so that it would reflect 445 nm and passes 515 nm. Coating files of
the excitation filter and emission filter were also defined accordingly. The light power
detected on the detector surface was 1.276 mW, which was approved to be very close to
the value we measured from the experimental setup.

Figure 2-7: Simulation of fiber bundle light coupling
Left: Illumination simulation using the ray profile provided by the manufacturer. Right: detector
image on a surface placed on the proximal end of the fiber bundle. The detected power was 1.28
mW

2.2.4 System assembly
In addition to the components that have been determined by simulation results and
based on the use of fluorescence dye. Optomechanical components were used to fix the
position of the optical components and ensure a good alignment. Figure 2-8 illustrates the
assembly of the FLI system. All the components are shown at their relative locations. It is
important to note that proper orientation of the filters is helpful to maximize performance
and minimize autofluorescence. Most mounted filters have an arrow located on the edge
of the filter to aid orientation. The dichroic beamsplitter (9) should be mounted with the
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coated surface toward the light source (13), excitation filter (11), and the objective lens
(4). The excitation filter (11) should be placed with the arrow pointing toward the cage
cube (7), and away from the blue LED (13) light source. The emission filter (10) should
be positioned with the arrow pointing toward the objective lens (4) and away from the
camera (16).

Figure 2-8: Exploded view of all components for FLI
Exploded view showing the relative locations of (1) FC/PC adapter, (2) 1" Long lens tubes, (3) 1"
Long lens tube coupler, (4) 20× objective lens, (5) RMS adapter, (6) 0.5" Long lens tube, (7) 30
mm cage cube, (8) end cap, (9) dichroic beamsplitter, (10) emission filter, (11) excitation filter,
(12) condenser lens, (13) 455 nm blue LED, (14) 2" Long lens tube, (15) 16×eyepiece lens, (16)
Samsung Galaxy S6 cellphone, (17) cage cube platform, (18) optic mount, and (19) blank cover
plate.

The most challenging step of the assembly procedure is to properly align the LED
(13), dichroic beamsplitter (9) and objective lens focus to deliver maximum power to the
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fiber bundle when it connects to the FC/PC adapter (1), while the fiber bundle remains in
focus. This alignment can be completed in three steps.
First, attach the fiber bundle to the FC/PC receptor (1), adjust the distance
between the FC/PC adapter (1) and objective lens (4) by rotating the lens tube coupler (3)
so that a clear and sharp image of the fiber bundle can be captured using the camera. The
position of the FC/PC adapter (1) is now optimized, and it should be locked using the
lock ring on the lens tube coupler (3). The imaging focus is fixed on the proximal end of
the fiber bundle after this step unless the distance between an objective lens and eyepiece
lens is altered.
Second, point the distal end of the fiber bundle to a light power meter, adjust the
position of the LED (13) to maximize the light intensity exiting the distal end of the fiber
bundle. The position of the LED (13) is optimized when the highest power is achieved.
Secure the LED (13) in this position using the lock ring on the lens tube coupler.
Third, after completion of the device assembling, slightly rotate/adjust the cage
platform with the dichroic beamsplitter mounted on it and measure the power coming out
of the fiber. The highest power is achieved when the dichroic beamsplitter is optimally
aligned and it should be firmly secured at this location.
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Figure 2-9: The completed smartphone FLI system
Left: the completed FLI system with major optic components. Right: picture of the completed
FLI system with a 3D-printed enclosure, and the fiber bundle attached.

2.3 PERFORMANCE CHARACTERIZATION
2.3.1 Imaging a uniform fluorescence reference slide
In the prototype shown in Figure 2-9, a 20× plan objective and a 16× wide-field
eyepiece were selected in combination with the cellphone camera lens to obtain a proper
magnification. The actual imaging area filled 1730 pixels in diameter of the camera
sensor array, which represents an image size of 1730×1.4 μm ≈ 2.4 mm in diameter,
resulting in 4× magnification (2.4 mm/0.6 mm). Therefore, each fiber occupied ~36
pixels of a raw image. The locations of the proximal end of the fiber bundle and the
condenser lens were adjusted so that all pixels in the bundle were uniformly illuminated
and clearly imaged onto the camera.
A green fluorescence reference slide (2273-G, Ted Pella) was used to check the
uniformity of the system. Figure 2-10 shows a representative image of the proximal end
of the fiber bundle when its distal end was in contact with the reference slide. A close
look of the image marked by the red box in Figure 2-10 indicates that individual fibers of
the bundle were well resolved.
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Figure 2-10: Fluorescence image of a uniform fluorescence reference slide

2.3.2 Fiber bundle pixelation artifact removal
While the fiber bundle brings the flexibility of the endoscopic imaging system, its
honeycomb pattern artifact also brings inherent noise to the image. A variety of methods
for removing the fiber bundle pixelation have been proposed. Generally, the processing
methods can be classified into two groups, of which one is filtering and smoothing, and
the other is interpolation reconstruction. Göbel et al. smoothed the image using Gaussian
filtering on images obtained in a two-photon endoscope system.[135] However, the
filtering method actually blurs the image, deteriorates the contrast of the image. Winter et
al. proposed using different types of adaptive filters in the frequency domain to process
the image[136] Similarly, Suter et al. used a low-pass filter to process the image in the
frequency domain, filtering out the high-frequency components and retaining only the
low-frequency information in the image.[137] However, choosing the right filter would
become much more complicated if the images contain more complex frequency
components. Han et al. proposed a method that histogram equalization was first applied
before Gaussian filtering.[138] This method improved the imaging quality and minimized
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the loss of details when the fiber bundle artifact was removed. Elter et al. proposed a
method of interpolation reconstruction.[139] The center of each fiber was obtained first,
and the pixel values at these locations were used to reconstruct the original image by
interpolation.
Since the intensity within each fiber has a Gaussian distribution, the intensity at
the center of each fiber represents the fluorescence intensity collected by that fiber. In
this work, we employed the interpolation reconstruction method to eliminate the fiber
pattern artifacts in the fiber bundle imaging. Figure 2-11 illustrates the steps to do
intensity correction and image reconstruction.

Figure 2-11: Flowcharts for image calibration and fiber pattern removal

First, the image measured from the uniform fluorescent reference slide is used to
calibrate the illumination distribution of the fluorescence images. The imaging area of the
fiber bundle was defined as the region of interest (ROI) and circularly cropped out of the
image. The regional maxima (fibers) within the defined ROI were extracted using a built-
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in Matlab function ‘imregionalmax’. The function returns a binary image consisting of 1s
at regional maxima and 0s elsewhere. Consequently, the location of fiber centers was
given by the coordinates of 1s in the binary image. A lookup table consisting of the fiber
center locations was created. Pixel values at these locations in the calibration image were
extracted to form a correction matrix. Next, pixel values of a raw fluorescence image at
locations that correspond to those in the lookup table were extracted to create a new
image, which was divided by the correction matrix using an element-by-element
operation to correct for the intensity fluctuation within each fiber. Next, the image was
converted to a gray-scale intensity image. The final step was to assign the extracted
center pixel values to the neighboring pixels to reconstruct a comb structure free image.

Figure 2-12: Fiber pattern removed image of the uniform fluorescence reference slide

It is important to note that the built-in Matlab function ‘imregionalmax’ can only
process images with regional peaks that have maximum connectivity of 26 or less, the
raw images with a fiber occupying 36 pixels (on the camera sensor) was scaled to half of
its original size. Given that the resolution of the imaging bundle is limited by the centerto-center distance of two adjacent fibers, reducing the image size to half doesn’t change
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the spatial resolution of the system. The fiber pattern rejected image of Figure 2-12. The
pixelation artifacts were effectively removed in the reconstructed image.
2.3.3 Spatial resolution characterization
To characterize the spatial resolution of the smartphone microendoscope,
fluorescence images were taken from a 1951 USAF resolution test target that was placed
on top of a green fluorescent reference slide. Figure 2-13(a) and (b) demonstrate the raw
and fiber pattern rejected images of the test target, respectively. The intensity function
across the lines (not shown) indicates that the valley intensity between the Group 7
Element 2 lines is 3dB below the peak value, while less than 3dB for that of the Group 7
Element 3 lines. This demonstrates that the microendoscope successfully resolved the
adjacent lines of Element 2 in Group 7, as can also be visually seen from the enlarged
area in Figure 2-13(b). Thus, the spatial resolution was estimated to be about 3.3 μm.
This value meets our expectation that the resolution of the setup is limited by the centerto-center distance between two adjacent fibers of the imaging bundle, which is about ~3.5
μm.

Figure 2-13: Fluorescence images taken from a 1951 USAF resolution target
(a) raw image; (b) fiber patter removed image
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2.3.4 Fluorescence imaging of biological samples
Ex vivo porcine adipose and bovine skeletal muscle tissues were also imaged
using the prototype FLI microendoscope. Fresh porcine and bovine tissues were obtained
from a local butcher’s shop within 3 hours of the slaughter of the animals. Experiments
were conducted immediately after the tissues were transported to the lab in a cooler. The
tissues were sliced into a dimension of 2×2×1 cm (W×D×H). Proflavine at a
concentration of 0.01% wt/vol was applied on the surface of the sliced tissues using a
cotton swab, and fluorescence images were taken immediately after in a dark room.
Typical images are presented in Figure 2-14. The white lipid cells and muscle fascicles
are both clearly visible. The brighter backgrounds between the cells of the adipose
samples are likely due to the non-specific binding of excessive proflavine on the tissue,
which may be reduced by rinsing the sample before imaging.
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Figure 2-14: Fluorescence images of ex vivo tissue
Raw and fiber pattern removed image of ex vivo porcine adipose tissue (a, b) and bovine skeletal
muscles (c, d).

To test the feasibility of the microendoscope for imaging living cells, both cell
lines and oral mucosa from a volunteer (IRB review exempted) were imaged. Images
were taken immediately after proflavine (0.01% wt/vol in PBS) was applied on the
surfaces of the cells or oral mucosa. The experiment setup and procedures to take images
from a single layer of L929 cells in a disk were the same as that used for the ex vivo
tissues. To image the oral mucosa, the fiber bundle was handheld and brought in gentle
contact with the inner cheek of the volunteer. Figure 2-15(a) and (b) show the raw and
fiber pattern rejected fluorescence images collected from the L929 cells. The cells can be
easily identified with little overlap. It is important to note that the bright spots in the
images represent the nuclei instead of the cells because proflavine selectively labels the
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cell DNA. Figure 2-15(d) and (e) show the raw and fiber pattern rejected images
collected from the oral mucosa. The nuclei of the mucosal cells can be clearly visualized
with some background fluorescence, which is attributed to the underlying cells and tissue
scattering.

Figure 2-15: Fluorescence images of ex vivo cell line and in vivo oral mucosa tissue
(a) Raw and (b) processed fluorescence images of a single layer of L929 cells. (c) Raw and (d)
processed images of normal human oral mucosa in vivo.

2.3.5 Quantitative information: nuclear-cytoplasmic ratio
The images were further processed to extract quantitative information about the
samples, such as cell density for cell lines and nuclear-cytoplasmic ratio (N/C) for
tissues. The mean projected nuclear area of normal cervical cell is ~36.2 μm2 which
occupies at least four pixels/fibers of the imaging bundle, while the average nuclear area
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of carcinomatous cell is 81.28 μm2.[140] As we mentioned earlier, other studies reported
that the LSIL cells have expanded nuclei that are at least three times (in area) as big as
the normal nuclei, and HSIL cells have similar expanded nuclei with reduced
cytoplasm.[13] Therefore, although the spatial resolution of the device limits its capability
to separate two cell nuclei that are less than 3.5 μm apart, the increased size/area of the
cell nuclei can readily be detected. Quinn et al.[53] demonstrated that the use of N/C
measured from 26 patients in Botswana has achieved a sensitivity of 86% and specificity
of 87% in differentiating CIN2+ lesions from non-neoplastic cervical tissues. A median
filter was used to reduce the outliers and bring out the core of the bright fluorescent dots.
Then the images were inverted to emphasize the dots. Finally, an ‘unsharp mask’ with a
radius of 5 made the images even sharper, as shown in Figure 2-16(a) and (b). From
Figure 2-16(a), it was determined, using a particle analysis function of ImageJ, that there
was a total of 852 cells within the ROI. Thus, the cell density was 2973 cells/mm2, which
is very close to the number estimated from a phase contrast microscope image (~3100
cells/mm2). The N/C of the oral mucosa was calculated to be 3.5%.
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Figure 2-16: Inverted images for N/C extraction
Inverted image of (a) cell line, and (b) oral mucosa tissue. (c) N/C extraction procedures

2.4 DISCUSSION
The results obtained with the prototype smartphone FLI system demonstrate the
feasibility of using the smartphone microendoscope for high-resolution fluorescence
images. We have constructed a benchtop HRME system, as shown in Figure 2-17(left,
top), based on the technology developed by Pierce et al.[72] The system consists of a 1.4
megapixel monochromatic CCD camera with a pixel size of 6.45 µm (Point Grey
Research, Inc., Canada), a blue LED, a Dichroic mirror, a 10× infinite corrected objective
lens, excitation and emission filters, a fiber-optic imaging bundle, and a laptop computer
loaded with custom software for image processing. Figure 2-17(right, top row) shows the
images taken with the HRME system from a 1951 USAF resolution test target, ex vivo
adipose and skeletal muscle of bovine tissues, and oral mucosa of a healthy volunteer,
respectively. Proflavine at the concentration of 0.01% wt/vol (in PBS) was applied on the
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surfaces of the tissue samples prior to imaging. The tissue images clearly show cell nuclei
and tissue structures. Given that the pixel size of smartphones is much smaller than that
of the CCD camera in the HRME, high excitation and better imaging optics may be
required to obtain fluorescence images of similar quality. Fluorescence images taken
using the smartphone-based FLI device were presented in Figure 2-17(bottom). The
image quality is comparable to that achieved with the high-resolution microendoscopes
(HRME) based on a scientific camera or a DSLR camera[74].

Figure 2-17: Compare between smartphone-based FLI system with HRME
Left: photographs of the benchtop HRME system and our smartphone-based FLI system. Right: images
taken from a 1951 USAF resolution target, ex vivo adipose and skeletal muscle tissues, healthy oral mucosa
from volunteers, and using the HRME system (top) and a Samsung smartphone (bottom). The images in
each column are not from the same sample.

However, the smartphone microendoscope has several advantages over the
HRME and DSLR camera systems. First, scientific or DSLR cameras cost over $1,000
and very few people own one. Smartphones, especially low-end or used smartphones, are
widely available at low cost (<$100) even in rural areas in LMIC. In particular, being
able to use customers’ existing smartphones for imaging significantly increases the
adoption of the technology in resource-poor settings. Second, the HRME uses a local
computer to collect or download images and often requires a trained engineer on site to
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operate the system. The smartphone microendoscope does not need a local computer and
the application software can be made easy to use, thus further reduces the cost associated
with each use of the device in LMIC. More importantly, due to the convenient Internet
access through a mobile data plan that is more widely available than a Wi-Fi network, a
smartphone microendoscope is more likely to be used as a point-of-care device for
telemedicine applications. Finally, our prototype system with a 3D printed enclosure
measures about 20×15×5 cm (L×W×H) and weighs only 612 grams. 3D printing of the
whole attachment (except the optical components, e.g., LED, lenses, and filters) will
make the device even more compact and portable. The final version of the smartphone
microendoscope can be readily engineered to a handheld device.
The total cost of the current smartphone microendoscope apparatus is about
$2,000. The primary costs include the imaging fiber bundle ($1,000 for two meters),
optical components (~$1000). We expect that the cost for a future prototype will be
reduced to $1,000 by batch ordering of the imaging bundle and optical parts as well as
using 3D printing technique for the mounting components and enclosure. The final
version of the microendoscope for LMIC will include an App (for Android) that is
capable of processing the images on the smartphone or sending them to a remote server
for processing and receiving the diagnosis.
The biggest challenges in implementing the smartphone microendoscope are: (1)
the much smaller sensor pixel size of a smartphone camera than that used in the HRME
systems and (2) the unchangeable built-in lens kit. Due to the low throughput of the
imaging bundle, it is critical to optimize the efficiency of the imaging optics so that a
comparable signal-to-noise ratio can still be achieved with the smaller pixels of the
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smartphone cameras. An eyepiece has also been used with the objective lens to correctly
image the fiber bundle on to the smartphone camera through the built-in lens kit.
Although the microendoscope described in this report was specifically designed for
proflavine as the contrast agent, it can be readily modified for other fluorescence dyes by
selecting a LED wavelength and filters that match the excitation/emission spectra of the
stain. Almost all smartphone cameras in the market use CMOS sensors, which are
sensitive to fluorescence in the visible and near-infrared wavelength range.
The high-resolution smartphone microendoscope allows imaging of subcellular
organelles, such as cell nuclei of the mucosa of the cervix, from which the nuclearcytoplasmic ratio can be determined. The technology can also be readily adapted for
imaging suspicious tissues in other internal organ sites, including the GI tracts (colon,
liver, esophagus, bladder, pancreas and stomach), prostate, lung, ovarian and oral cavity.
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ChapterCHAPTER 3: SMARTPHONE DIFFUSE REFLECTANCE SPECTROSCOPY

In this chapter, we described the design and development of a smartphone-based
spectrometer for diffuse reflectance measurement. The design was first simulated and
optimized in Zemax to evaluate the feasibility. The developed DRS system was
characterized and calibrated using two calibration lamps. An optical resolution of 2 nm
was estimated, which is comparable to a commercially available benchtop spectrometer
(>$5000). Phantom validation was performed to evaluate the accuracy of the system in
measuring diffuse reflectance and extracting optical properties based on Monte Carlo
simulation. An averaged error of less than 5% was achieved, which is also as good as a
commercial spectrometer that has been extensively verified in clinical studies. Therefore,
the smartphone-DRS system has a great potential to provide a cost-effective solution in
measuring tissue optical properties and is ready to be combined with other techniques
such as FLI to obtain complementary tissue information.
3.1 DIFFUSE REFLECTANCE SPECTROSCOPY
Imaging and spectroscopy are two major groups of optical techniques that are
used for biomedical applications. Imaging techniques, such as fluorescence imaging
discussed in chapter 2, provide qualitative information by visualizing the morphological
structure of the tissue. On the contrary, spectroscopic techniques are able to provide
quantitative information of the biochemical or functional properties of the tissue by
studying the light-tissue interactions such as absorption and scattering.[141]
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3.1.1 Diffuse reflectance
The phenomenon in which the light emitted into a sample scatters multiple times
and eventually comes out is called light diffusion. As illustrated in Figure 3-1, photons
that propagate in the tissue will undergo scattering and absorption. Some of the photons
are absorbed by specific molecules such as hemoglobin and nucleic acids. Others are
scattered multiple times by scatters in the tissue such as mitochondria and cell nuclei, and
escape from the tissue in random directions. Diffuse transmission occurs when the
emitted light passes through the sample and comes out on the other side. On the other
hand, diffuse reflection happens when the outcoming light and the incident light are on
the same side. Both the diffuse transmission and diffuse reflections light carry the internal
information of the sample, and thus can be collected and analyzed to determine the
intrinsic properties of the sample. However, because visible light can only travel for a
limited distance in turbid media, the diffuse transmission is less feasible for most
applications.

Figure 3-1: Schematic representation of light-tissue interaction
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3.1.2 Tissue optical properties
Absorption coefficient 𝝁𝒂 . For the visible light, light absorption in tissue is
mainly caused by molecules like hemoglobin, melanin and other pigments. The
absorption of light can be described by the absorption coefficient (𝜇𝑎 ), which represents
the light extinction due to absorption. The absorption coefficient is wavelength
dependent, and it is largely affected by the blood content and oxidation state. Figure 3-2
shows the absorption spectra of oxyhemoglobin (HbO2) and deoxy-hemoglobin (Hb).[142]
It can be seen that HbO2 and Hb have very different absorption characteristics across the
whole wavelength range, especially at a wavelength longer than 600 nm. The absorption
coefficient of most biological tissues is within the range of 0.1 to 10 cm-1.[143]
Scattering coefficient 𝝁𝒔 . The scattering of light in turbid media is usually
characterized using the scattering coefficient (𝜇𝑠 ), which is similar to the absorption
coefficient that indicates the light energy loss due to scattering. The uneven refractive
index of tissue causes scattering and it depends on the size, density and morphological
structure of the tissue contents such as collagen fibers, mitochondria, lipid membrane and
nuclei. For example, the water-like lipid membrane interface surrounding each cell and
inside a cell has a different refractive index from the gel-like fibrils in the intercellular
substance. When both the absorption coefficient and scattering coefficient are given, the
total attenuation/extinction coefficient can be obtained as 𝜇𝑡 = 𝜇𝑎 + 𝜇𝑠 .
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Figure 3-2: Absorption spectra of HbO2 and Hb
(Photo credit: Scott Prahl, OMLC. Reference 131)

Anisotropy factor 𝒈. When a scattering event occurs, the trajectory of the photon
is deflected by an angle θ. Each deflection is random, and it can be described using the
Henyey-Greenstein phase function, which represents the probability distribution of the
1

photon deflection angle 𝜃 at which the scattering event occurs: 𝑃(𝜃) = [

1−𝑔

1
√1+𝑔2 −2𝑔 cos 𝜃

]⋅

1−𝑔2
2𝑔

−

, where 𝑔 is the scattering anisotropy factor, which is equal to the

average of the cosine of the scattering angle: 𝑔 = 〈cos 𝜃〉 that measures how much the
forward direction is retained after a scattering event. For most soft tissues, the value of 𝑔
is between 0.65 and 0.95.[143] When 𝑔 = 1, 0 or -1, it corresponds to three special cases of
totally forward scattering, isotropic scattering and totally backward scattering.
Reduced scattering coefficient 𝝁′𝒔 . The introduction of the reduced scattering
coefficient is to simplify the description of multiple scattering of photons within the
biological tissue. The process in which photons are scattered for multiple times at a step
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size of

1
𝜇𝑠

can be simplified as a single scattering event with a step size of

1
𝜇𝑠′

, where

1
𝜇𝑠′

is

called the reduced scattering free path and 𝜇𝑠′ is the reduced scattering coefficient. The
reduced scattering coefficient connects to the scattering coefficient through the equation
𝜇𝑠′ = 𝜇𝑠 (1 + 𝑔). It is important to note that the reduced scattering coefficient does not
follow the superposition principle because the anisotropy factor does not change with
concentration of scatters so that the reduced scattering coefficient is no longer linearly
related to the concentration.
3.1.3 Modeling of light-tissue interaction using Monte Carlo simulation
Two different methods can be used to describe the absorption and scattering
properties of light in biological tissues, namely analytical method and approximation
method. The analytical method is based on Maxwell's equation and is the most basic
description method in principle. However, the process of deriving the analytical solution
is extremely complicated and not practical. Diffusion approximation, one of the most
widely used approximation methods, directly describes the migration of photons in the
absorption and scattering process. The feasibility of diffusion approximation has been
experimentally verified.[144,145] However, the diffusion approximation model is only
suitable when the scattering coefficient is much larger than the absorption coefficient
(𝜇𝑠 ≫ 𝜇𝑎 ) and when the source-detection-separation (SDS) is much longer than the free
pass of photon migration.[146]
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Figure 3-3: Illustration of source-detection-separation

In this study, the SDS is designed to be less than 1 mm in order to obtain enough
signal using the optical fiber and the cellphone camera whose sensitivity is much lower
than a scientific camera or photodetector, as illustrated in Figure 3-3. Therefore, diffusion
approximation is not the best option for providing high accuracy in this application.
Monte Carlo modeling of light reflectance developed by Lihong Wang et al.[147,148] offers
a better flexibility in terms of range of optical properties and the tissue geometry being
studied due to the following advantages: 1) it has no limitation on the light source or
boundary conditions so that it can equally be applied to single-layer or multi-layer
structures; 2) it does not need to solve the transmission equation and is computationally
simple; 3) it has no requirements of the optical parameters and hence works for media
that are not scattering dominant. While detailed description about the Monte Carlo
simulation of photon migration in tissue and sample programs can be found in reference
[129] and [130], the basic idea of this method is described as follows.
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To simplify the problem, photons are treated as neutral particles and the light
incident is perpendicular to the surface of the tissue. Each photon has an initial weight of
1 and a random travel step s =

ln 𝜉
𝜇𝑡

at its injection into the tissue, where 𝜉 is a random

number uniformly distributed between 0 and 1, 𝜇𝑡 = 𝜇𝑎 + 𝜇𝑠 is the total attenuation
coefficient due to absorption and scattering. At each step it travels, the photon will be
partially absorbed and partially scattered. Absorption causes the weight of the photon to
𝜇

decay. The amount of weight loss is 𝛥𝑤 = 𝑤 ⋅ 𝜇𝑎, where 𝑤 is the weight at the current
𝑡

𝜇

position. Photon carrying the remaining weight 𝑤 − 𝛥𝑤 = 𝑤 𝜇𝑠 continues to transmit in
𝑡

the tissue. From the equations above, it is easy to see that the weight of the photon decays
𝜇

exponentially with a rate of 𝜇𝑠 . While absorption reduces the weight of the photon,
𝑡

scattering changes the direction of propagation. After the photon is scattered, the travel
distance 𝑠 for the next step will be updated. The scattering angle 𝜃, so as the anisotropy
factor 𝑔, gives the new direction of movement of the scattered photon. As we mentioned
in the previous section, the probability of distribution of the cosine of the scattering angle
𝜃 is defined by the Henyey-Greenstein phase function.
Consequently, a photon can either be absorbed by absorbers inside the tissue or
escape from the tissue after multiple scattering events. For a photon that exits the tissue,
it is treated as naturally terminated and the tracking of photon stops. For a photon that
keeps propagating in the tissue, the tracking stops when the weight of photon decays to a
value less than a preset threshold wTH (e.g., wTH = 0.00001). In this way, the Monte
Carlo method simulates a large number of photons (in millions) individually as they
transport in the tissue. A distribution of photon density at each position of the tissue can
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be obtained. In homogenous media, the distribution is roughly banana-shaped between
the light source and detector if photons are perpendicularly injected on the same surface
of the media (Figure 3-3).
The major drawback of the Monte Carlo simulation is that it is computationally
intensive that requires long computation time, especially when simulating a large number
of photons. Different approaches have been reported to speed up the simulation.[57,149-151]
In this study, a flexible and fast Monte Carlo model proposed by Palmer et al.[151] was
used to extract the optical properties of the tissue or tissue-mimicking phantoms. This
model has been validated for absorption coefficient at a range of 0 - 20 cm-1 and reduced
scattering coefficients of 7 - 33 cm-1 with high accuracy and has been extensively tested
in tissue-mimicking phantoms[152,153] and multiple preclinical[154,155] and clinical
studies[18,75,79,156,157]. Beyond this, the model is easily adaptable to arbitrary probe
geometry and can be used with a single phantom calibration.
A brief description of Palmer’s model is summarized as follows. The model
consists of a forward model and an inverse model, as shown in Figure 3-4. The forward
model uses pre-determined absorption coefficient, scattering coefficient and anisotropy
factor to model the diffuse reflectance. Absorption coefficient 𝜇𝑎 is determined by the
extinction coefficient 𝜀𝑖 of the chromophore and its concentration C𝑖 according to the
linear relationship 𝜇𝑎 = 𝛴 𝑙𝑛(10) ⋅ 𝜀𝑖 (𝜆) ⋅ 𝐶𝑖 . Scattering coefficient 𝜇𝑠 and anisotropy
factor g are modeled using Mie theory for spherical particles.[158] It is important to note
that instead of running a simulation for each set of optical properties (𝜇𝑎 , 𝜇𝑠 , g), a scaling
approach[159] was used in this fast Monte Carlo model to increase the efficiency of
computation so that only one single simulation for a given set of 𝜇𝑎 , 𝜇𝑠 , g was required.
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In the inverse model, initial parameters including chromophore concentration, size and
density of scatterers are loaded into the forward model to model the diffuse reflectance as
the predicted values. The measured (unknown) reflectance is then iteratively compared to
the predicted values until the sum of squares error between them is minimized. In this
way, a set of optical properties (𝜇𝑎 , 𝜇𝑠 , g) of the measured reflectance can be extracted.
From the optical properties, the tissue parameters such as oxy-hemoglobin concentration
(HbO2), deoxy-hemoglobin concentration (Hb), total hemoglobin concentration (THb),
and tissue regional saturated oxygenation (rSO2) can be accurately determined.

Figure 3-4: Forward and inverse models of Palmer’s fast Monte Carlo simulation
(Photo credit: Palmer et al. Adapted from reference [133]). Left: forward model; Right: inverse
model.

3.2 OPTICAL DESIGN
3.2.1 System layout
The smartphone-based diffuse reflectance spectrometer consists of a smartphone
with a rear camera and imaging optics. A schematic diagram of the smartphone
spectrometer is shown in Figure 3-5. The imaging optics include an aspheric lens for light
collimation, an optical slit and a transmission grating. The DRS channel uses a white
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LED as the light source. The white light is delivered to the tissue through two 200/220
µm multimode fibers, as shown in the end view of the DRS probe in Figure 3-5. Diffuse
reflectance is collected by a single detection fiber, collimated by a collimating lens and
then narrowed down by a 100 µm slit. The collimated lights are diffracted by a
transmission grating and focused by the camera lens to be imaged on to the image sensor
of the smartphone. The source-detector separation (center-to-center distance between the
source fibers and the detection fiber) is 0.75 mm.

Figure 3-5: Schematic diagram of the smartphone-based DRS
CL – collimating lens; LED - light-emitting diode; GND – ground; SW – ON/OFF switch

3.2.2 Ray-tracing simulation
Prism and diffraction grating are two optical components that are commonly used
to split the light in the design of a spectrometer. An optical prism disperses the light
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based on the refractive effect, i.e., different wavelengths have different refractive indices
so that they can be separated when passing through a prism. Generally, the shorter the
wavelength, the larger the deflection angle. In the meantime, the resolution of the prism
is higher at the shorter wavelength, which is not desirable in the design of a spectrometer
from the perspective of “uniformity” or “linearity”. A diffraction grating uses the multislit diffraction effect to decompose the light. It is usually a piece of flat glass or metal
engraved with tens of thousands of parallel lines/slits. The formation of light through the
grating is a combined result of single slit diffraction and multi-slit interference. When the
complex light passes through the grating, the lines of different wavelengths appear at
different positions to form a spectrum. When compared to a prism, the spectrum
generated by a diffraction grating is relatively uniform, and the distance between two
spectral lines with the same wavelength difference does not vary. The uniformity of the
grating spectrum not only makes the spectrum easier to calibrate, but also facilitates the
preliminary judgment of the wavelength value of the spectral line for qualitative analysis.
Ray tracing simulation software such as Zemax provides the feature to design and
model diffractive components. Diffractive surfaces in Zemax are modeled based on the
grating equation[160]: 𝑑(𝑛2 sin 𝜃2 − 𝑛1 sin 𝜃1 ) = 𝑚𝜆, where d is the line spacing, 𝑛1 and
𝑛2 are refractive indices, 𝜃1 is the angle of incidence, 𝜃2 is the angle between the
diffracted light and the grating's normal vector, m is the diffraction order and 𝜆 is the
wavelength. In this design, the incident light with wavelength 𝜆 propagates in the air and
normally hits the grating as depicted in Figure 3-6, therefore 𝜃1 = 0, 𝑛1 = 𝑛2 ≈ 1. From
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the grating equation, the diffraction angle 𝜃2 can be derived as 𝜃2 = sin−1

𝑚𝜆
𝑑

=
1

sin−1 𝑁𝑚𝜆, which depends only on the line spacing (d) or the groove density 𝑁 = 𝑑.

Figure 3-6: Diagram showing light incident normally to a transmission diffraction grating

Throughput and optical resolution are the two most important characteristics of a
spectrometer. Generally, there is a tradeoff between resolution and throughput, and they
really depend on the specification of the components to be used, especially the grating
and slit. For example, grating with a higher groove density has a broader dispersion
(nm/pixel) for the same wavelength range; Slit with a smaller entrance (slit width) has a
better pixel resolution. Consequently, using a high groove density grating together with a
narrower slit will significantly increase the resolving power. However, the signal strength
decreases with an increase in the groove density or decrease in the slit width, leading to a
lower signal to noise ratio. Simulation of the DRS design is to evaluate whether the
proposed combination of the grating (1200 grooves/mm) and slit (100 µm) can provide
enough signal strength with acceptable spectral resolution, and to determine the distances
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between components. In this study, throughput is more critical because diffused light
signal through tissue that can be collected by the optical fiber is extremely weak.
Therefore, the efficiency of the grating is not the most critical factor to be examined in
this design, it is assumed to be 100% in Zemax although it depends on the structure of the
diffractive surface in the real situation. In the LDE shown in Table 3-1, a groove density
of 1200 g/mm and a slit width of 100 µm were assigned to the diffraction grating and slit,
respectively. The 1st diffraction order was specified to be simulated. The optimized
geometries and simulated spectral image at the camera sensor (last surface in the design)
are shown in Figure 3-7. Discrete wavelengths range from 400 nm to 600 nm with an
interval of 10 nm were used in the simulation.

Table 3-1: Values defined in the LDE for DRS
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Figure 3-7: Ray-tracing simulation of the DRS system
(a) Elements from left to right: collimating lens, 100 µm slit, 1200 g/mm transmission grating,
and cellphone camera with lens and sensor. (b) Simulated spectral image of the 1st diffraction
order given discrete wavelengths range from 400 nm to 600 nm with 10 nm intervals.

3.2.3 System assembly
Figure 3-8 illustrates the construction of the DRS system. All the components are
shown at their relative locations. It is important to note that the aspheric lens (4)
(Thorlabs C110TMD-A) has a relatively short focal length of 4 mm so that it should be
placed very close to the FC/PC adapter (1) where the detection fiber will be connected to.
A 100 µm slit (Thorlabs S100RD) and 1200 grooves/mm grating (Thorlabs GT13-12)
were used to obtain enough signal and, in the meantime, to have adequate resolving
power. It is important to note that because a multimode fiber with a diameter of 200 µm
and numerical aperture (NA) of 0.22 is used, the relatively larger diameter of the fiber
may become the limiting factor of the system resolution even if narrower slits were being
used.
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Figure 3-8: Exploded view of all components for DRS
Exploded view showing the relative locations of (1) FC/PC adapter, (2) 2" long lens tubes, (3)
SM1 to M9 x 0.5 lens adapter, (4) mounted aspheric lens, (5) 1" long lens tube coupler, RMS
adapter, (6) 100 µm slit, (7) 1" long cage assembly rods, (8) 0.5" long lens tubes, (9) cage, (10)
grating holder, (11) 1200 groove/mm transmission grating, (12) Samsung Galaxy S6 cellphone.

Another important factor worth attention is the collimation of light. Ideally, light
pass through a collimating lens or a collimator should have a fixed size of the beam.
However, no collimation is perfect because there is no actual point source. Consequently,
the beam divergence must be considered in the design. Figure 3-9 shows the collimation
of light from a fiber. A fiber with a radius of 𝑟1 is placed at the focal point (𝑓) of the
collimating lens. The maximum ray of angle out of the fiber is 𝜃1 . The beam size will be
determined by the NA of the fiber and focal length of the collimating lens so that 𝑟2 =
𝑟1 + 𝑓 ⋅ tan 𝜃1 . Given that the radius of the fiber is usually much smaller than the focal
length and tan 𝜃1 ≈ 𝜃1 , the radius of the collimated beam can be simplified as 𝑟2 ≈ 𝑓 ⋅
𝑟

𝜃1 and increases as it propagates away from the lens with a divergence angle 𝜃2 ≈ 𝑓1.[161]
From the equations derived above, the beam size is directly proportional to the focal
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length while the divergence angle is inversely proportional to it. In other words, there is
also a tradeoff between the beam diameter and the divergence angle. Obtaining a smaller
size of beam spot will at the expense of better collimation.

Figure 3-9: Collimation of light from a fiber
(Photo credit: Newport. Adapted from reference 160)

In our design, the radius and numerical aperture of the fiber is 100 µm (𝑟1) and
0.22, respectively. Therefore, the maximum ray of angle 𝜃1 equals to 0.22 or 12.7°.
Given that the focal length of the collimating lens used in the design is 6.24 mm, the
radius of the beam is calculated to be 1.37 mm and the divergence angle of 0.016 or 0.9°.
These values are suitable for our application because the slit has a maximum length of 3
mm that is wider than the beam diameter. We wanted to collect as much light as possible
to achieve the maximum throughput. The complete smartphone-based DRS is shown in
the figure below.
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Figure 3-10: The completed smartphone DRS system
Left: the completed DRS system with major optic components. Right: picture of the completed
DRS system housed in a 3D-printed enclosure, and the fiber-optic probe attached.

3.3 PERFORMANCE CHARACTERIZATION
3.3.1 Wavelength calibration and resolution verification
Two calibration lamps, krypton (6031, Newport) and neon (6032, Newport), were
used for wavelength calibration of the DRS system because they have multiple narrow
and intense peaks in the visible range. The raw images of the calibration light sources
captured by the device are presented in Figure 3-11. A window of 1500×60 (X×Y) pixels
(red box) was used to crop out the 1st diffraction order dispersed spectra. The cropped
image was then converted to grayscale, and 60 Y-axis pixel values at the same X location
were added up to represent the intensity.

Figure 3-11: Raw and cropped spectral images of calibration lamps
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The wavelength calibration was performed by identifying the known peak
wavelengths of the calibration lamps and the corresponding pixel positions of the peaks
in the spectra. Thirteen peak wavelengths across the range of 420 – 640 nm were
identified based on the data sheet provided by the manufacturer[162], as shown in Figure
3-12.

Figure 3-12: Peak wavelengths used for wavelength calibration

The peak wavelengths and pixel positions were fitted with a third-degree
polynomial fitting (cubic polynomials) to generate a calibration equation 𝑌 = 𝑎𝑋 3 +
𝑏𝑋 2 + 𝑐𝑋 + 𝑑 so that wavelength can be calculated based on it. In the equation, Y is the
wavelength, X is the pixel location, and a, b, c and d are coefficients. Table 3-2 provides
the calibrated wavelength values calculated using the following cubic function: 𝑌 =
−1.01328 × 10−8 ⋅ 𝑋 3 + 1.94689 × 10−5 ⋅ 𝑋 2 + 0.19222 ⋅ 𝑋 + 395.32166. The
differences between the calibrated and known values were within the range of -0.45 nm
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to 0.26 nm. The total wavelength range of a 1500-pixel spectrum was calculated to be
395.5 nm to 693.3 nm. Therefore, the dispersion was about 0.2 nm/pixel. The spectral
resolution of a spectrometer was usually defined as the full width at half maximum
(FWHM) of monochromatic light. At the peak of 557.03 nm in Figure 3-12, the FWHM
was 10 pixels. Therefore, the spectral resolution was estimated at 2 nm (0.2 nm/pixel
multiply by 10).

Table 3-2: Wavelength calibrated using third-degree polynomial fitting

To further verify the resolving power of the DRS device, a spectral image of a
handheld laser source with a wavelength ~635 nm (HLS635, Thorlabs) was taken. The
typical spectrum of the output light provided by the manufacturer was shown in Figure 313(c). The wavelength of the light source is centered at ~637 nm and has short tails on
both sides. The spectrum detected using the smartphone-based DRS device were given in
Figure 3-13(a), (b), and (d). The sharp peak is centered at 636.3 nm and has an FWHM of
~2 nm, which confirms the optical resolution of the device.
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Figure 3-13: Spectrum of a monochromatic light source
(a) Raw and cropped spectral image of a 635 nm handheld laser source; (b) Wavelength
calibrated spectrum taken by smartphone-based DRS; (c) typical spectrum of the light source
provided by the manufacturer; (d) FWHM indicated that the resolution is about 2 nm.

3.3.2 Phantom validation
To characterize the accuracy of the DRS channel in measuring optical properties
of biological samples, 14 tissue-mimicking liquid phantoms with a mean absorption
coefficient (𝜇𝑎 ) averaged over the wavelength range from 430 -630 nm between 1 cm-1 3 cm-1 and a mean reduced scattering coefficient (𝜇𝑠′ ) between 7 cm-1 - 12 cm-1 were
created using powdered human hemoglobin (H0267, Sigma Aldrich) as absorbers and 1.0
µm polystyrene microspheres (07310, Polyscience, Inc.) as scatterers (Table 3-3). The
expected 𝜇𝑎 of the phantoms were independently determined from absorbance
measurements of the stock hemoglobin solution using a UV/Vis spectrophotometer
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(LAMBDA 35, PerkinElmer Inc.) and scaled to the actual concentrations in the
phantoms. The expected 𝜇𝑠′ was computed from the density, size, and refractive index of
the polystyrene spheres using Mie theory.[147,158]

Table 3-3: Expected phantom properties averaged over 430 nm – 630 nm
Phantom #
1
2
3
4
5
6
7

a

 s'

(cm-1)

(cm-1)

1.02
1.26
1.48
1.69
1.88
2.05
2.21

11.64
11.14
10.67
10.25
9.86
9.49
9.15

Phantom #
8
9
10
11
12
13
14

a

 s'

(cm-1)

(cm-1)

2.37
2.51
2.64
2.76
2.88
2.99
3.09

8.84
8.55
8.27
8.01
7.77
7.54
7.33

A raw picture of the spectral image is shown in Figure 3-14. Spectra were taken at
an exposure time of 0.25 second. The 1st order diffractions were cropped out and
calibrated using the cubic function obtained in the previous section. Averaged smoothed
raw spectra of all of the 14 phantoms are also provided in the following figure. The
spectral intensity decreases as the concentration of hemoglobin increases because more
light is absorbed within the phantom.

Figure 3-14: Spectra of liquid phantoms

66
Left: A sample picture (phantom #5) of the raw and cropped spectral images measured from
liquid phantoms; Right: Wavelength calibrated spectra of all 14 phantoms (intensity of spectrum
decreases while the phantom number increases).

The absorption and reduced scattering coefficients 𝜇𝑎 and 𝜇𝑠′ were extracted from
the measured spectrum of each phantom using the scaling inverse Monte Carlo model
discussed in the first section. The extracted parameters were compared to the expected
values, as shown in Figure 3-15. Specifically, the difference between the extracted and
expected values (error) was calculated and divided by the expected value. An average
error of 6.9% and 5% were obtained for 𝜇𝑎 and 𝜇𝑠′ .

Figure 3-15: Extracted vs. expected 𝝁𝒂 and 𝝁′𝒔 for all phantoms

3.4 DISCUSSION
A benchtop DRS system has been developed in our lab to quantify the optical
properties of epithelial tissues. As shown in Figure 3-16(left, top), the spectrometer
consists of a three-channel fiber-optic USB spectrometer (Avantes BV, The Netherlands)
and a laptop with custom LabVIEW and Matlab software. This commercial spectrometer
covers a wavelength range of 400 - 635 nm with a spectral resolution of 1.8 nm. Liquid
phantoms covering a similar range of absorption and scattering coefficients used for the
smartphone-based DRS validation were employed to evaluate its performance. Figure 3-
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16(right, top row) shows the results of the phantom experiment as extracted versus
expected wavelength averaged 𝜇𝑎 and 𝜇𝑠′ calculated from the spectra. A mean error of
1.4 % and 6.8% were obtained for 𝜇𝑎 and 𝜇𝑠′ , respectively. The error bars in the plots
were due to the different reference phantoms. As a comparison, for the smartphone-based
DRS, mean error of 6.9% and 5% were obtained for 𝜇𝑎 and 𝜇𝑠′ . The results are
comparable to those of the benchtop DRS system, as shown in Fig. 3-16(right, bottom
row).

Figure 3-16: Compare between smartphone-based DRS system with a commercial
spectrometer
Left: photographs of the benchtop DRS system and experimental SmartME-DRS (w/o FLI
channel). Right: results of a liquid phantom experiment using the commercial system (top) and
smartphone-based DRS (bottom).

Clinical study has been conducted by different groups using a similar benchtop
spectrometer and Monte Carlo model to reveal the underlying sources of absorption and
scattering contrast in 39 cervical cancer patients.[79] A significant increase in total
hemoglobin concentration was observed in CIN2+ compared to CIN1 lesions and normal
tissues. In the meantime, a decrease in mean scattering 𝜇𝑠′ was observed in CIN2+
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compared to CIN1 and normal tissues. The result is consistent with others who carried
out quantitative spectroscopy of the cervix.[100,163]
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Chapter CHAPTER 4: A DUAL-MODALITY SMARTPHONE MICROENDOSCOPE
FOR QUANTIFYING THE PHYSIOLOGICAL AND MORPHOLOGICAL
PROPERTIES OF EPITHELIAL TISSUES

Portions of this chapter are derived from the manuscripts submitted to Scientific Reports:
Xiangqian Hong, Tongtong Lu, Liam Fruzyna, and Bing Yu. A Dual-modality
Smartphone Microendoscope for Quantifying the Physiological and Morphological
Properties of Epithelial Tissues. Scientific Reports. Submission ID: SREP-19-05266.
In the previous two chapters, we present the development of a smartphone-based
fluorescence microendoscope and a smartphone-based spectrometer individually. In this
chapter, we further developed a dual-modality fiber-optic microendoscope (named
SmartME) that integrates the high-resolution FLI and quantitative DRS onto a
smartphone platform for noninvasive quantification of the tissue physiological and
morphological properties of epithelial tissues. The SmartME has a spatial resolution of
~3.5 µm for FLI and accuracy comparable to those of a benchtop DRS system for
measuring the tissue absorption and scattering properties.[75] When used with the App, the
device can be used to perform FLI and DRS on epithelial tissues, wirelessly transfer the
data to a remote server for data processing, and potentially return the results to the
SmartME within seconds or a few minutes. Our preliminary studies have demonstrated
that the dual-modality SmartME can accurately characterize the biological properties and
provide complementary information about epithelial tissues. The SmartME has great
potential to provide a compact, cost-effective, and ‘smart’ solution for early detection of
neoplastic changes in epithelial tissues, especially in low resource settings.
4.1 HARDWARE DEVELOPMENT
4.1.1 SmartME instrumentation
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A schematic diagram of the SmartME device is shown in Figure 4-1. The system
consists of a smartphone (Samsung Galaxy S6), a miniature fiber-optic endoscope, a
phone attachment containing the imaging optics, and an Android Application (App). The
system includes two functional channels, an FLI channel and a DRS channel. The details
of the configurations of each channel have been described in chapter 2 and 3,
respectively. Briefly, a blue LED (455 nm, M455L3, Thorlabs) coupled with a condenser
lens (ACL2520U-A, Thorlabs) and a short-pass excitation filter (FF01-452/45, Semrock)
are used for fluorescence excitation. The excitation beam is redirected by a dichroic
beamsplitter (DBS, AT485DC, Chroma Technology) towards a 10× microscope objective
which focuses the excitation lights onto the proximal end of a fiber bundle in the
endoscope. The fluorescence emissions are collected by the same fiber bundle at the
distal end, propagate through the objective, DBS and a long-pass emission filter (FF01550/88, Semrock) that blocks the excitation lights, and then are collimated onto the rear
camera of the smartphone by a 16× eyepiece. The imaging fiber bundle (FIGH-30-650S,
Fujikura) has an imaging area of 600 μm and consists of 30,000 individual fibers with a
center-to-center distance of ~3.3 μm. The choice of the blue LED, filters and dichroic
beamsplitter for the FLI is based on the use of proflavine.
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Figure 4-1: Schematic diagram of the SmartME
A schematic diagram of the SmartME and an end view of the miniature dual-modality fiber-optic
endoscope (EP - eyepiece; BP1 & BP2 - optical bandpass filters; DBS - dichroic beamsplitter;
OBJ - microscope objective; CL1 - condenser lens; CL2 – collimating lens; LED - light emitting
diode; GND - ground; SW - ON/OFF/ON switch).

The DRS channel uses a white LED (MCWHF2, Thorlabs) as the light source.
The white light is delivered to the tissue through two 200/220 µm multimode fibers
attached along with the imaging fiber bundle, as shown in the end view of the endoscope
in Figure 4-1. Diffuse reflectance is collected by a single detection fiber, narrowed down
by a 100 µm slit (S100RD, Thorlabs), and then collimated by a collimating lens. The
collimated lights are diffracted by a 1200 grooves/mm transmission grating (GT13-12,
Thorlabs) and then imaged on to the rear camera of the smartphone. The source-detector
separations (center-to-center distance between the source fibers and the detection fiber)
are 0.75 mm. The LEDs are powered by the same rechargeable batteries and turned
on/off sequentially using a 3-position switch. Both the FLI and DRS channels were
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designed and optimized using a combination of the sequential and non-sequential modes
in OpticStudio (Zemax LLC).

Figure 4-2: The completed SmartME device
Left: the assembly of the SmartME device by combining the FLI and DRS module using 3D
printed adapters and a slide mechanism. Right: a picture of the combined SmartME device.

The front-face camera has also been tested for the DRS during the development.
However, compared to the rear camera, the front-face camera has a much lower imaging
quality, and its focal length is fixed. Therefore, using the front-face camera requires a lot
of trial-and-error testing to get an acceptable alignment, while the performance of DRS
may still be vulnerable to a minimal misalignment. Consequently, the rear camera was
used for both FLI and DRS. A sliding mechanism with a fixed moving distance was
installed so that the phone can be switched back and forth smoothly to achieve different
imaging functions one at a time. The two channels were combined and protected using
3D printed parts that specially made for this design.
4.1.2 Fabrication of miniature fiber-optic probe
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The imaging fiber bundle and three DRS fibers were integrated into a fiber-optic
endoscope of less than 3 mm in diameter, shown in Figure 4-3. The imaging bundle has
30,000 pixels with a pixel size of ~3 µm and an imaging area of 0.65 mm in diameter. At
the distal end of the probe, three 200 µm DRS fibers were mounted along with the
imaging bundle, two for DRS illumination and one for detection of diffuse reflectance.
The center-to-center distance between the source and detection fibers (or SDS) was about
750 µm. According to our simulation with the Monte Carlo forward model with a range
of optical properties representative of typical epithelial tissues, this SDS provides a
penetration depth of 0.5-2 mm for the wavelength range of 450-630 nm[75], which would
be sufficient to catch most precancerous (CIN1 - CIN3) lesions in the epithelium and
stroma layers of the cervix. At the proximal end, the endoscope broke out into three
branches. The imaging bundle was connected to the port for fluorescence imaging. The
source fibers were connected to a white LED, and the detection fiber was connected to
the port for diffuse reflectance spectroscopy. The distal end of the probe was housed in a
surgical grade stainless-steel tube so that it can be easily cleaned and sterilized in the
medical application.

Figure 4-3: Picture of the integrated dual-modality endoscope probe
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Left: A picture of the dual-modality probe. The fiber bundle was protected using a stainless-steel
armor jacket. The DRS fibers were protected using 3mm blue jacket. Right: an end view of the
probe. All optic fibers were housed in a stainless-steel tubing of 3mm in diameter.

4.2 SOFTWARE DEVELOPMENT
4.2.1 Smartphone App development
An Android App has been developed to configure and control the SmartME, preprocess the fluorescence and DRS images, and wirelessly transfer the fluorescence
images and diffuse reflectance spectra. The Android App allows a user to set and save the
camera parameters, initiate a measurement, store the measured data, display the spectra,
perform simple analysis on the results such as gray-scale image conversion and
wavelength calibration and communicate with the Cloud services and server. Figure 4-4
shows the architecture of the App workflow. The App consists of two primary interfaces,
one for the acquisition and processing of fluorescent images and the other for the
collection and processing of spectral images. They are independently controlled and the
settings are saved separately.
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Figure 4-4: Architecture of the smartphone App

During a procedure, a doctor can use a patient ID or name to retrieve the PHI
from the hospital’s electronic medical records (or manually entered, if not available) and
display it on the screen. For each new SmartME procedure, a unique ID related to the
patient ID was generated. The App also assigns a site number and a measure number for
each measurement saved, and the measure number increases automatically after
completion of one scanning. Figure 4-5 shows the screenshots of the main menu and
interfaces of the FLI and DRS modules. Measurement information, including the site
number, measure number, integration time (for DRS and FLI), and diagnosis status will
be displayed on the screen. The remote server downloads the data from the Cloud
performs the image/spectral analysis and diagnosis (the images could be read by a
physician as well) and returns the results to the App for display.
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Figure 4-5: Screenshots of the SmartME App
Left: the home screen of the App that allows the operator to enter the patient/subject information
and configure the settings for the measurement. Middle: the user interface of the FLI module.
The focus and exposure time can be manually controlled to obtain the best imaging quality.
Right: the user interface of the DRS module. Both the raw spectral image and spectrum were
displayed for better visualization during measurement.

While it is impossible to go over all the details of the App, several critical features
that specially designed are presented as follows. In order to increase the speed of data
transmission and processing, the DRS spectrum within the region of interest is cropped
out, wavelength calibrated and converted to a text file in the App before sending to the
server for further analysis using the Monte Carlo inverse model. A window of 1500
pixels × 60 pixels is defined in the setting, as shown in Figure 4-6. A saturation check is
then performed in the background before proceeding to wavelength calibration. A
warning window will pop out if any pixels of the image becomes saturated. Recall that
there are four coefficients in the cubic equation for wavelength calibration. These
calibration parameters are saved in the App so that spectral images without saturation are
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automatically calibrated and converted to a text file for display and data transfer, as
shown in Figure 4-6.

Figure 4-6: Image snipping and wavelength calibration in the App
Left: the setting window to define the area to be cropped out. Middle: A green window covering
the whole spectrum is set for image snipping. Right: Coefficients obtained from the cubic
equation (chapter 3) are saved in the App for wavelength calibration.

4.2.2 Wireless communication with the server
Data collected by the App are wirelessly transmitted to the server through remote
access with IP address. Data analysis are performed in the remote server where the image
processing algorithms and Monte Carlo model are loaded. A custom tool named
“SmartME Uploader” was developed and installed on the server to ensure a smooth
connection between the SmartME and the server. Figure 4-7 shows the interface of the
SmartME uploader software. To create a connection between the device and server, IP
address and port number should be typed into the App, and a user account of the operator
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should be created. Once the connection is established, data files will be uploaded to the
server in real-time whenever a measurement is taken.

Figure 4-7: SmartME remote server

It takes less than 1 second for the App to transmit one data file to the server. A
message will pop up on the server once the data files (image and text file) are
successfully received. In the meantime, the successful data reception activates data
processing modules. With the help of the fast Monte Carlo model, the inversion takes less
than a second to extract the optical properties of the measured diffuse reflectance. The
processed results are saved in the server and also sent back to the SmartME device for
display. Figure 4-8 presents the results displayed in the App that are processed by the
remote server. On the measurement page, the real-time display of the results for the most
recent measurement is designed to disappear in 5 seconds. However, the results of all the
analyses are saved in the App and available for browsing.

79

Figure 4-8: Display of results in the App
Left: the real-time display of the data for current measurement disappears in 5 seconds or
overwritten by the next measurement. Right: results files are also saved in the App.

4.3 PERFORMANCE VERIFICATION AND IN VIVO STUDY
4.3.1 System performance characterization
The performance of the combined SmartME has been characterized using similar
procedures described in Chapter 2 and 3. Briefly, the spatial resolution of the smartphone
FLI was estimated by taking fluorescence images of a 1951 USAF resolution test target.
The smallest pair of lines in the fluorescence images that can be successfully resolved
was Element 2 in Group 7. Thus, the spatial resolution was estimated to be about 3.5 μm,
which is high enough to resolve the cell nuclei.
For the DRS, wavelength calibration using neon and krypton lamps was
conducted. The resolving power was estimated to be 2 nm based on the FWHM method.
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Liquid phantom experiments combined with the fast Monte Carlo inverse model were
conducted to test the accuracy in measuring diffuse reflectance. The inversion process
was repeated 14 times (for all 14 phantoms), in each inversion one phantom was selected
as a reference to analyze all phantoms.[151] The percent errors, which are the difference
between the extracted and expected values in µ𝑎 and 𝜇𝑠′ divided by the expected values,
were computed. An averaged accuracy of 95% in measuring diffuse reflectance was
obtained. Among all phantoms, the phantom #9 was selected as the reference to calibrate
the SmartME DRS channel for tissue measurements because it yielded the smallest error.
4.3.2 Ex vivo measurements of biological samples

Figure 4-9: Fluorescence images of HeLa cells
(a)-(c): Raw and processed fluorescence images taken by SmartME FLI module. (d) and (e):
phase contrast images taken by a microscope. Because the fiber-optic probe touched the cells
during measurement, the cell distribution in the circled-out area (green) of the microscopic image
was not exactly the same as it appeared in the fluorescence image.
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Monolayer HeLa cells (cervical cancer cell line) grown in a disk was imaged
using the SmartME-FLI. Proflavine at a concentration of 0.01% (wt/vol in PBS) was
applied on the surface of the cells. The fiber-optic probe held on a Z-stage was adjusted
until a clear image can be obtained. The end of the probe had a gentle contact with the
cells. Figure 4-9(a)-(c) are raw and processed fluorescence images collected from the
HeLa cells using the SmartME and miniature fiber-optic probe. The cell nuclei are clearly
visualized with some background fluorescence, which is attributed to the excessive
proflavine in the culture medium. Figure 4-9(d) and (e) are two phase contrast images at
different magnifications. To further verify the capability of the device in imaging tissue
samples, tumor tissue harvested from a nude rat xenograft model (breast cancer 4T1,
epithelial) was imaged in vitro using the SmartME FLI. As shown in Figure 4-10, the
cancer cells are densely packed. The tumor tissue is highly hypoxic (almost white in
color) leads to a lot of reflectance background lights. Besides, fluorescence light from the
cells of deeper layers is scattered by the surface layer. Therefore, the contrast of the
fluorescence image of the tumor tissue was not as good as the contrast of monolayer cell
line.
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Figure 4-10: Fluorescence image of tumor tissue in vitro

4.3.3 In vivo measurements of healthy oral tissue
To test the feasibility of the SmartME for quantitative characterization of
epithelial tissue properties, three types of healthy oral mucosa tissues, including labial
mucosa, gingival tissue and tongue dorsum, from a healthy human volunteer were imaged
in vivo. The experiment was conducted on the researcher himself. The subject in this selfexperiment fully understood the procedures and gave his consent to participate in the
experiment voluntarily. Exempt determination was received from Marquette University's
Institutional Review Board (IRB). All methods were performed in accordance with the
relevant guidelines and regulations of the institution. Before the optical measurements,
the volunteer was asked to rinse his mouth with a 0.9% saline solution. The SmartME
endoscope was cleaned using 2% chlorhexidine digluconate in ethanol. Eight random
sites were imaged from both labial mucosa and tongue dorsum tissues, while five random
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sites were measured from gingival tissues. All measurements were taken under dimmed
room light. To take a measurement, the endoscope was handheld and brought in gentle
contact with the tissue. Diffuse reflectance spectra were collected by turning on the white
LED and switching the SmartME App to the DRS mode. A diffuse reflectance spectrum
was taken from a diffuse reflectance standard puck (Spectralon, Labsphere) for
calibration purpose following the tissue measurements. A background spectrum was also
collected and subtracted from all tissue spectra and the puck spectrum.
Immediately following the DRS measurements, the surface of the same tissue
sites was topically stained using cotton swabs with proflavine at a concentration of 0.01%
wt/vol (in PBS) for 15 seconds, and then rinsed with PBS to remove excessive
fluorescence dye. Fluorescence images were taken by turning on the blue LED and
switching the App to the FLI mode. Each of the twenty-one tissue sites was imaged five
times by slightly shifting the endoscope within the area of interest, resulting in a total of
105 diffuse reflectance spectra and 105 fluorescence images. All the spectral data and
fluorescence images were saved in the App and wirelessly transferred to the remote
server for further processing to extract the biological properties using the methods
described below.
The image reconstruction method discussed in chapter 2 has been employed using
MATLAB to eliminate the fiber pattern artifacts in the fluorescence images. The imaging
area of the fiber bundle was defined as the region of interest (ROI) and circularly cropped
out of the whole raw image. The intensity within each fiber has a Gaussian distribution.
Therefore, the intensity at the center pixel of each fiber (which occupies multiple pixels
on the smartphone camera) represents the fluorescence intensity collected by that fiber
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and is assigned to the neighboring pixels within the fiber to construct a comb structure
free image. The image was then converted to a binary image in ImageJ to calculate the
N/C for the selected ROI using the built-in particle analyzer.
The fast Monte Carlo inverse model of reflectance discussed in Chapter 3 was
loaded in the remote server to analyze the diffuse reflectance spectra. The diffuse
reflectance spectra of the liquid tissue phantoms were used to extract the 𝜇𝑎 and 𝜇𝑠′
between 450 nm and 630 nm. The tissue hemoglobin concentrations were computed from
the extracted µ𝑎 using the Beer-Lambert law. Phantom #9 of the phantom experiment
was selected as the reference to invert the diffuse reflectance spectra of the oral tissues.

Figure 4-11: DRS and FLI measurements of healthy oral tissues
(a) Normalized representative diffuse reflectance spectra and (b) typical raw fluorescence images
measured from healthy gingival tissue, tongue dorsum and labial mucosa in vivo.
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Figure 4-11(a) shows representative diffuse reflectance spectra from three healthy
oral sites that are normalized by (point-by-point) dividing the puck spectrum. The two
major absorption bands (α and β bands) of oxyhemoglobin are clearly visible in the
spectra. The measured spectra of the three types of oral tissue are different from each
other in shape and intensity, representing the difference in their underlying physiological
and morphological characteristics. Typical raw fluorescence images taken from the three
oral tissues are shown in Figure 4-11(b). The bright spots in the images represent the
nuclei instead of the cells because proflavine selectively labels the cell DNA.
Reduced scattering coefficients 𝜇𝑠′ and total hemoglobin concentrations (THC)
were extracted from the tissue spectra using the Monte Carlo inverse model. Assumed
that both the 𝜇𝑠′ and THC are normally distributed, Student’s t-tests were performed using
Minitab to test if there are significant differences among the three tissue types. Interval
plots using the individual standard deviation of extracted THC and 𝜇𝑠′ are presented in
Figure 4-12(a) and (b), respectively. Each dot in the plots represents the average of 5
repeated measurements taken from the same tissue site. Although the optical properties
vary from site to site even for the same tissue type, the variation within each group of
tissue type is generally smaller compared to differences between different tissue types.
The extracted THC of labial mucosa is significantly higher than that of gingival and
tongue tissues (P < 0.001). The THC of gingival and tongue tissues are also significantly
different from each other (p<0.003). While the extracted 𝜇𝑠′ of the tongue dorsum is
significantly lower than gingival tissue and labial mucosa, there is no significant
difference between gingival tissue and labial mucosa (P = 0.60).
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The reconstructed, fiber pattern free fluorescence images for three representative
tissues are presented in Figure4-12(c). The inverted and enhanced images were further
processed to extract the N/Cs for the tissues. The average N/C (overall sites of the same
tissue type) is 4.4 ±0.6 (%) for gingival tissue, 4.1 ±0.5 (%) for tongue dorsum and 3.9 ±
0.8 (%), for labial mucosa. Consequently, the results suggest that the intervention of DRS
measurements can provide diagnostically complementary information about the samples
in question when it has difficulty in differentiating the tissues by using FLI alone.

Figure 4-12: Quantitative analysis of tissue properties
(a) Interval plots of extracted total hemoglobin concentration and (b) extracted wavelengthaveraged reduced scattering coefficient for three oral tissue types (gingival, labial and tongue).
Each dot represents an average of 5 repeated measurements from the same tissue site. P-values
are calculated using two-sided Student’s t-test at a significance level of 5%; (c) Representative,
fiber pattern removed fluorescence images of the three oral tissues and the inverted images used
for N/C calculation.
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4.4 DISCUSSION
We have developed a dual-modality smartphone fiber-optic microendoscope that
integrates quantitative DRS and high-resolution FLI into a portable, cost-effective and
globally connected device. The SmartME can noninvasively quantify the optical
properties, hemoglobin concentrations and the nuclear-cytoplasmic ratio of epithelial
tissues. The ability to measure these tissue parameters at low cost has a significant impact
on epithelial cancer and pre-cancer detection in low-resource settings. In a clinical study
for cervical cancer detection using DRS conducted by Chang et al.[79], a significant
increase in THC and a decrease in mean 𝜇𝑠′ were observed in high-grade neoplasia
compared to low-grade lesions and normal tissues. Hornung et al.[163] and Georgakoudi et
al.[100] also observed a decreasing trend in 𝜇𝑠′ (P = 0.16) in high-grade neoplasia using
spectroscopy. In a review article by Thekkek et al.[51], DRS was shown to have achieved
sensitivities and specificities in the ranges of 83 – 92% and 80 – 90% for cervical
precancer detection. High-resolution FLI also allows differentiating high-grade neoplastic
changes from their low-grade and normal counterparts using the N/C. For example, a
sensitivity of 86% and specificity of 87% were achieved using N/C in differentiating
high-grade lesions from non-neoplastic cervical tissues in 26 cervical cancer patients by
Quinn et al. [53]. A large advantage of the SmartME system is that it combines the
benefits of both FLI and DRS to provide complementary information that can be used to
improve the sensitivity and specificity in differentiating different epithelial tissue types.
Therefore, the SmartME has great potential to be used for imaging of neoplastic changes
in oral mucosa and cervical tissues as well as gastrointestinal tract tracts.
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The implementation of the SmartME system is intended to provide a costeffective solution for precancerous screening in resource-limited settings. The integration
of optical imaging technologies on a smartphone platform can significantly reduce the
cost, weight and size, while maintains the high performance in the meantime. The total
cost of the current SmartME device is less than $2500, among which the major costs are
from the imaging fiber bundle, light sources and fluorescence filters. The cost may be
further reduced by batch ordering and mass production, making it even more affordable
to LMIC. More importantly, the App developed for the SmartME has the ability to send
the images collected on site to a remote server for diagnostic analysis. The smartphonebased diagnosis could potentially be used as a point-of-care device for telemedicine
applications in LMIC where multiple clinical visits are not feasible and centralized
laboratories do not exist.
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CHAPTECHAPTER 5: CONCLUSIONS AND SUGGESTED FUTURE WORK

5.1 SUMMARY
The scope of this dissertation was to design and develop a cost-effective
smartphone-based endoscope system that can perform both high-resolution fluorescence
imaging and diffuse reflectance spectroscopy for early detection of cervical neoplastic
changes. Figure 5-1 shows the development and prototyping history of the device.

Figure 5-1: The development history of SmartME

In Chapter 2, development procedures and performance characterization of the
smartphone-based fluorescence imaging device were discussed. The results showed that
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the imaging resolution (3.5 µm) and contrast of the device were as good as the benchtop
system that had been verified in clinical studies, while the smartphone-based device was
more cost-effective and easier to use. Chapter 3 presented the design and development of
a fiber-optic smartphone-based spectrometer. While the spectrometer was very compact,
the performance of the device, including optical resolving power (2 nm) and accuracy
(95%) in measuring diffuse reflectance, was comparable to a commercial spectroscopy
system. Chapter 4 further combined the two modalities onto the smartphone platform to
obtain a dual-modality device SmartME. The rear camera was shared by two modules
due to the hardware limitations of the front-face camera. Biological samples including
monolayer HeLa cells and ex vivo tumor tissues (4T1) were imaged using the SmartME.
The results showed that cell nuclei were clearly visualized when fluorescence agent
proflavine was applied on the sample surfaces. Beyond this, an in vivo study of healthy
human oral tissue using the SmartME was conducted to verify its capability to
quantitatively characterize the epithelial tissue properties. Three types of normal oral
mucosa tissues, including labial mucosa, gingival tissue and tongue dorsum, were
measured by both modalities. Optical and tissue properties such as scattering coefficient,
total hemoglobin concentration and nuclear-cytoplasmic ratio were extracted from the
diffuse reflectance spectra and fluorescence images using a fast Monte Carlo inverse
model and image processing algorithms. The results showed that the measured spectra of
the three types of oral tissue are significantly different from each other in shape and
intensity due to different absorption and scattering properties, representing the difference
in their underlying physiological and morphological characteristics. Since all
measurements were taken on normal tissues, the N/Cs were similar across all three types
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of tissues, which met our expectation. However, with the help of DRS, tissue types were
successfully distinguished from each other that otherwise impossible if solely based on
N/Cs obtained from FLI.
5.2 SIGNIFICANCE OF THIS WORK
From the 1990s, improving the medical conditions of all human beings and
scaling healthcare innovations worldwide have now become the consensus of people
from all over the world. However, as stated in a report by WHO in 2003, quote:
“… a significant proportion of the world’s population, especially in developing countries,
has yet to derive much benefit from innovations that are commonplace elsewhere. The reasons
range from weak supply systems to unaffordable prices. The factors that drive innovation are
often biased against conditions that disproportionately affect the populations of developing
countries. … Innovation to address conditions primarily affecting poor people is held back by a
combination of market failure and underinvestment by the public sector. The process of bringing
a new product to the market is both expensive and lengthy. …”[164]

While there is still a long way to go to improve the healthcare conditions in
LMICs, we are committed to developing medical devices that are suitable and practicable
for LMICs. Figure 5-2 shows how the SmartME can be combined with VIA/VIAM to
screen and detect cervical neoplastic changes in LMICs. Without the SmartME, all
abnormal lesions identified by VIA/VIAM (low specificity) will be biopsied, leading to a
large number of unnecessary biopsies. With the SmartME, only the patients with the
highest likelihood of having CIN2+ will be biopsied, thus reducing the number of
unnecessary biopsies that might otherwise be taken for diagnosis. In the long-term, if this
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combined strategy is proven to be highly specific, it can enable a see-and-treat paradigm
in which a diagnosis of CIN2+ could immediately be followed by cryotherapy or LEEP,
thereby preventing the need for biopsy and multiple clinical visits.

Figure 5-2: Benefits of using SmartME in clinical applications

This study is an application of the translational research concept that takes
advantage of recent advancements in high-resolution fluorescence imaging, optical
spectroscopy and Mobile Internet technology, and aims at improving or transforming
current cancer diagnostic practice in LMICs. The work is scientifically innovative in
three aspects: hardware, software, and optical biomarker discovery. The compact
integration of FLI and DRS into a miniature fiber-optic endoscope on to a smartphone
platform is a key innovation, which enables high-resolution imaging and quantitative
endoscopy to be affordable, portable and easy-to-use. Another innovation is that the
smartphone App not only allows data collection but also connects the device and operator
in a low-resource setting to a high-performance server loaded with custom image/spectral
processing and diagnostic software as well as experienced personnel in a developed area.
This new solution may transform the current on-site cancer diagnosis in LMICs to a
cloud-based online smart diagnosis paradigm. A third innovation is the discovery of
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biomarkers that best differentiate high-grade from low-grade lesions and their
normal/benign counterparts if the device is successfully validated in the clinical study.
5.2 FUTURE INVESTIGATIONS
We note that the current study on the SmartME is subject to several limitations.
First, the effect of acetowhitening phenomena on the FLI and DRS measurements
remains unstudied. Studies have shown that acetic acid increases the backscattering of
cell nuclei, which leads to images with increased contrast under confocal
microscopy.[11,29] Other studies reported that the backscattering from cytoplasmic fraction
dominates backscattering from nuclear or mitochondrial fractions after application of
acetic acid.[34] If both the reported findings mentioned above are correct, it is safe to
assume that the contrast of FLI measurements will not be affected much because the
fluorescence dye selectively stains the cell nuclei. However, the increased scattering
intensity from the cytoplasmic fraction will definitely increase the scattering readings if
DRS measurements are taken immediately after acetic acid application. Using scattering
coefficient to differentiate tissue types may become less effective. Consequently,
comparative experiments in a clinical setting should be conducted to fully investigate
whether acetowhitening effects will significantly affect the measurements taken by
SmartME device. Alternatively, since most acetowhitening effect starts to decay in 5
minutes after acetic acid application[28,31], a standardized procedure could be developed in
which SmartME measurements are only performed after acetowhite decay to bypass its
effect. Test accuracy is still the most important factor, given that the testing speed and
comfort are not significantly reduced.
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Second, because only one healthy subject was measured in our in vivo study, the
conclusions and findings may not be extended to all subjects. Many factors, including
race, gender, age, diet habit and physical conditions, may lead to higher inter-subject
variations. Future clinical studies that include both normal/benign tissue and cancer or
precancer are necessary to fully test its efficacy in early detection of cervical neoplastic
changes. We have recently contacted hospitals in developing countries in an attempt to
establish a collaborative clinical trial.
Finally, motion artifacts and probe-tissue contact pressure may also contribute to
differences in the tissue optical properties from site to site because it is challenging to
maintain a consistent pressure applied to the tissue by the endoscope.[75,165-167] Therefore,
device optimization both in hardware and software, such as including a pressure sensor
on the tip of the endoscope, adding another imaging modality or improving the
communication establishment between the device and the server, may be necessary to
improve the reliability and consistency.
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